Exploring risk factors for suicidality in adolescents with autism spectrum disorders by Kikoler, M. & Kikoler, M.
Canterbury Christ Church University’s repository of research outputs
http://create.canterbury.ac.uk
Copyright © and Moral Rights for this thesis are retained by the author and/or other 
copyright owners. A copy can be downloaded for personal non-commercial 
research or study, without prior permission or charge. This thesis cannot be 
reproduced or quoted extensively from without first obtaining permission in writing 
from the copyright holder/s. The content must not be changed in any way or sold 
commercially in any format or medium without the formal permission of the 
copyright holders. 
When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given e.g. Kikoler, M. (2018) 
Exploring risk factors for suicidality in adolescents with autism spectrum disorders. 
D.Clin.Psychol. thesis, Canterbury Christ Church University. 
Contact: create.library@canterbury.ac.uk
  
 
MAXIM KIKOLER BSc Hons MSc PGCert 
 
 
EXPLORING RISK FACTORS FOR SUICIDALITY IN 
ADOLESCENTS WITH AUTISM SPECTRUM DISORDERS 
 
 
Section A: Suicidality in children and adolescents with Autism 
Spectrum Disorders: A review of prevalence and risk factors 
Word Count: 7990 (plus 297 additional words) 
 
Section B: Suicidality in adolescents with Autism Spectrum 
Disorders: investigating Depression and Irritability as risk factors 
in a UK clinical population 
 
Word Count: 7784 (plus 518 additional words) 
 
 
Overall Word Count: 15,774 (plus 815 additional words) 
 
 
A thesis submitted in partial fulfilment of the requirements of  
Canterbury Christ Church University for the degree of  
Doctor of Clinical Psychology 
 
 
APRIL 2018 
 
 
SALOMONS  
CANTERBURY CHRIST CHURCH UNIVERSITY  
 
 
  
Acknowledgements 
 
Thank you to my supervisors, Dr John McGowan and Dr Jo Mueller, as well as Dr Johnny 
Downs, for their support and guidance over the course of the project. 
 
To my parents, thank you for supporting me, making it possible for me to pursue this path, 
but most importantly for never letting me give up on this dream – almost there! 
 
To Jules, your love and support kept me going when submitting didn’t look possible.  Thank 
you for feeding, watering, and encouraging me via your instastory.  You helped make this 
happen.  Now this is in, I’ll start cooking again. 
  
 
Summary of Major Research Project 
Section A examines the prevalence and risk factors associated with suicidality in children 
and adolescents with Autism Spectrum Disorders (ASD).  A systematic of the available 
research was conducted, yielding nine relevant papers. Findings indicated rates of suicidality 
in children and adolescents with ASD were being comparable to those reported for typically 
developing youth.  The research suggested a range of psychological and sociodemographic 
risk factors to be potentially associated with suicidality in children and adolescents with 
ASD. Methodological issues hindering generalisability of findings are outlined.  Implications 
for future research, as well as clinical practice, are discussed. 
 
Section B is an empirical study investigating the role of depression, irritability, and specific 
depressive profiles as risk factors for suicidality in adolescents with ASD in a UK clinical 
cohort.  Data from the electronic mental health records of 1314 adolescents diagnosed with 
ASD between 2008 and 2013 were analysed.  Suicidality was the outcome of interest, with 
depression, irritability, and specific depressive profiles as exposure variables.  Findings 
showed depression, irritability, and specific depressive profiles to be associated with 
suicidality in adolescents with ASD, alongside several sociodemographic risk factors. 
Strengths and limitations of the study are explored, as well as implications both clinical 
practice and future research. 
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Abstract 
Background & Objectives: Suicidality, a collective term encompassing both suicidal 
ideation and suicidal behaviour, has been identified as a significant health concern for adults 
with Autism Spectrum Disorders (ASD).  Emerging research suggests that suicidality is also 
a significant issue for children and adolescents with ASD.  This review evaluated the 
published literature investigating prevalence of suicidality in youth with ASD and its risk 
factors.  
Method: A systematic literature search of research from inception to December 2017 was 
conducted using three online databases.  Nine studies investigating suicidality and the associated 
risk factors in children and adolescents with ASD were identified.  Quality of study was 
evaluated individually. 
Results: Rates of suicidality in children and adolescents with ASD were found to be 
comparable to those reported for typically developing youth, with a range of psychological 
and sociodemographic risk factors potentially associated with suicidality in youth with ASD. 
Limitations & Conclusions: Generalisability of findings was limited due to several 
methodological issues, including inconsistency in suicidal phenomena investigated, non-UK 
samples, and heterogeneity in diagnosis of ASD between studies. Future studies should look 
to repeat with UK samples, as well as investigating specific risk factors to understand better 
the risk mechanisms associated with suicidality.   
 
Keywords: ASD, suicidality, children, adolescents, risk factors 
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Introduction 
Autism Spectrum Disorders (ASD) 
ASD is a collective diagnostic label representing a range of neurodevelopmental disorders.  
These disorders are typically categorised by deficits in the domains of social communication, 
social interaction and sensory processing, alongside repetitive stereotyped behaviours, rigid 
thinking style and highly specific interests, the presence of which occurs early on in a 
person’s development (American Psychiatric Association, 2013). With the publication of the 
Diagnostic and Statistical Manual 5th edition (American Psychiatric Association, 2013), ASD 
has become the collective term encompassing several specific diagnoses: 
• Autism/Autistic Disorder (AD): alongside the characteristics outlined above, 
individual receiving a diagnosis of AD will have also displayed clinically significant 
delay, prior to three years old, in a minimum of one of the following domains: 
o Social interaction 
o Language as a form of social communication 
o Imaginative/symbolic play 
• Asperger Syndrome (AS): unlike AD, individuals receiving a diagnosis of AS will 
have displayed no clinically significant delays in language, cognitive development, 
and adaptive behaviour. 
• Pervasive Development Disorder – Not Otherwise Specified (PDD-NOS): sometimes 
referred to as “atypical autism”, this diagnosis will have been given if an individual 
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displays significant impairment akin to AD but doesn’t meet full criteria for a 
diagnosis, or onset is after three years old. 
In the UK, assessment is based on ICD-10 criteria and is typically conducted using diagnostic 
tools, such as the Autism Diagnostic Observation Schedule 2nd Edition (Lord et al., 2012). 
Similar prevalence of ASD has been reported in adulthood and childhood.  In the UK, Brugha 
et al.(2012) reported 1.1% of the adult population having a diagnosis of ASD, whilst Baron-
Cohen et al.(2009) suggested ASD occurs in approximately 1% of the child population; 
however, Baron -Cohen et al.(2009) found a ratio of 2:3 when comparing known cases to 
undiagnosed cases, suggesting that rates may actually be higher than originally estimated.  
With regards to gender, ASD diagnosis is currently more common amongst males, with a 
male to female ratio of 4:1 commonly cited (Halladay et al., 2015).  However, in a recent 
systematic review by Loomes, Hull, and Mandy (2017), it was suggested that the gender ratio 
is actually closer to 3:1. Furthermore, it has been suggested that phenotypic presentation of 
ASD may differ between genders (Werling & Geschwind, 2013). 
As well as the associated social communication difficulties, ASD is associated with increased 
risk of co-occurring psychiatric disorders.  Simonoff et al.(2008) reported significantly higher 
rates of psychiatric disorders in youth with ASD compared to a similar study of rates within a 
general population sample, whilst Joshi et al.(2010) found, within a clinical population, youth 
with ASD suffered from significantly higher numbers of co-occurring psychiatric disorders 
than non-ASD controls. Kim, Szatmari, Bryson, Streiner, and Wilson (2000) found that 
children with high-functioning ASD were at greater risk of mood and anxiety problems than 
the general population.  Level of risk of co-occurring disorders may even differ between 
different ASD diagnoses: Mukaddes, Hergüner, and Tanidir (2010) found that children and 
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adolescents with AS were at greater risk of depression than individuals with diagnosis of 
HFA. Explanations for this increased prevalence remain unclear, but it has been suggested 
that the effects of presumed risks factor (both environmental and genetic) for psychiatric 
outcomes differ in children with neurodevelopmental disorders (Simonoff et al., 2013; 
Simonoff et al., 2008). 
Research also suggests that psychiatric presentation in ASD may differ from the general 
population.  Ghaziuddin (2005) posits that depression in ASD presents with “special 
features” (p.131); similarly, Magnuson and Constantino (2011) found that ASD-affected 
children may present with additional features, such as catatonia and mood lability. Depressive 
presentations may even vary between different ASD diagnoses (Pearson et al., 2006).  
Suicidality 
The National Strategy for Suicide Prevention (Center for Mental Health Services (US) & 
Office of the Surgeon General (US), 2001) defines “suicidality” as the collective term for a 
range of suicidal phenomena: 
• Suicidal ideation: thoughts pertaining to suicide/suicidal behaviour. 
• Suicidal plans: thoughts around method of carrying out suicidal behaviour. 
• Suicidal attempt: an unsuccessful attempt to engage in behaviour with intended 
outcome to die as a result of the act. 
• Completed suicide: death occurring as a result of direct behaviour intended to end 
one’s life. 
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Suicidality is globally recognised as a major public health issue.  Suicide is one of the leading 
causes of death for 5- to 19-year olds in the UK (Office of National Statistics, 2016), and the 
second leading cause of death globally amongst 10- to 24-year olds (Hawton, Saunders, & 
O'Connor, 2012). Thus far, research has focused predominantly on adolescent suicide, and 
not childhood trends.  A review by McLoughlin, Gould and Malone (2015) on global trends 
in adolescent suicide reported lifetime prevalence of suicidal ideation and suicide attempts 
ranging from 12.1%-29.9% and 4.1%-10.5%, respectively.  Risk factors for suicidality within 
typically-developing youth have been widely researched, identifying a range of factors: 
• Psychological disorder: depression, anxiety disorders, substance use disorder 
(Fergusson, Woodward, & Horwood, 2000) 
• History of sexual and/or physical abuse (Bruffaerts et al., 2010; Martin, Dykxhoorn, 
Afifi, & Colman, 2016) 
• Exposure to marital disruption/divorced parents (Fergusson et al., 2000; Fuller-
Thomson & Dalton, 2011) 
• Socioeconomic adversity (Dupéré, Leventhal, & Lacourse, 2009; Fergusson et al., 
2000) 
There have been a range of psychological theories proposed in an attempt to identify and 
explain the causal mechanisms that might lead to suicidal phenomena being expressed or 
experienced. According to Barzilay and Apter (2014), theoretical models can be categorised 
into the following: 
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• Psychological Pain theories: suicidality occurring as a response to significant 
emotional pain and the desire to escape distress (e.g. “Suicide as escape from self”, 
Baumeister, 1990). 
• Cognitive theories: suicidality occurring as a result of maladaptive thinking styles and 
negative attentional biases (e.g. Cognitive Model, Wenzel & Beck, 2008). 
• Stress-Diathesis theories: suicidality occurring as a result of an interaction between 
pre-existing vulnerability characteristics and an external stressor (e.g. Interpersonal 
Theory of Suicide, Joiner, 2007). 
ASD & Suicidality 
Suicidality within ASD populations is still a relatively new area of study.  Research into 
adults with ASD has shown suicidality also to be a significant health concern within this 
population.  Paquette-Smith, Weiss and Lunsky (2014), examining suicidality in adults with 
AS in a Canadian sample, found that 35% of their sample reported history of attempted 
suicide, significantly higher than lifetime prevalence of 4.6% reported by the general 
population, identifying depression and severity of AS presentation as risk factors. Cassidy et 
al.(2014) found that 66% of their sample of adults with AS reported lifetime experience of 
suicidal ideation, and 35% reporting historical planned/attempted suicide, the former of 
which was nine times greater than rates observed in the general population. Similar to reports 
by Paquette-Smith et al.(2014), Cassidy et al.(2014) found depression and high levels of 
autistic traits as risk factors for suicidality.  
Several case studies have also highlighted the relationship between suicidality and ASD in 
adults. Spencer et al.(2011), outlined the case of a 44-year old man who presented to hospital 
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after attempting to take his life through cutting his wrists, subsequently admitted to a 
psychiatric inpatient unit.  During admission, he was diagnosed with depression and ASD, the 
former of which resulted from difficulties in social interaction, which the authors posited to 
be related to core features of ASD.  Mikami, Ohya, Akaska, and Matsumoto (2006) described 
the case of a 23-year old male with a diagnosis of AS, who had attempted suicide through 
burning himself and had a history of two suicide attempts by hanging.  Through examination 
of predisposing factors, they identified low self-esteem stemming from relationship 
difficulties and resultant feelings of isolation, with difficulties in his relationship with his 
parents contributing to feelings of isolation.  Mikami et al. (2006) posited that core elements 
of tension between the young man and his parents were AS characteristics, such as lacking in 
emotional reciprocity and being unreasonably insistent on restrictive thinking, and his 
parents’ lack of comprehension of AS.  Both studies drew similar conclusions, emphasising 
the importance of ASD diagnosis to assist formulation, and to focus intervention on both 
ASD presentation and predisposing psycho-social factors as part of suicide prevention. 
In terms of suicidality in youth diagnosed with ASD, a case study by Mikami, Onishi, & 
Matsumoto (2014) described the case of a 17-year old male admitted to hospital after 
attempting suicide by jumping, fracturing his lumbar spine. During his admission he was 
diagnosed with ASD and adjustment disorder.  The authors formulated that the young man’s 
suicide attempt was related to low self-esteem stemming from pervasive difficulties in 
developing interpersonal relationships and consequent feelings of isolation, as well as poor 
communication with his parents since infancy due to his ASD presentation.  Furthermore, 
they suggested that delay in ASD diagnosis may have played a significant role in the extent 
of relationship difficulties and feelings of isolation, as well as expediting development of 
poor communication with his parents.  Mikami et al. (2014) described the effective use of 
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psychosocial intervention in preventing suicide reattempt, causing positive change in the 
patient’s parents’ attitude towards him, not only resulting in reduced feelings of low self-
esteem and social isolation but also a cessation in suicidal ideation. As with adult cases, they 
concluded that diagnosis of ASD, especially early diagnosis, is vital in suicide prevention, 
and that clinicians should hold in mind, alongside ASD traits, the impact of psychosocial 
predisposing factors for suicide when developing intervention. 
However, given the novelty of this topic, research on suicidality in individuals with ASD and 
the relationship with risk factors identified in the general population is currently limited. 
Aims of the Review 
Current literature, albeit sparse, suggests suicidality to be a significant issue for youth with 
ASD.  Therefore, this review aimed to explore and summarise the research investigating 
suicidality in children and adolescents with diagnoses of ASD, guided by the following 
research questions:  
1. How prevalent is suicidality amongst children and adolescents with ASD? 
2. What does the research tell us about the risk factors associated with suicidality in this 
population? 
Methodology 
Literature Search 
A systematic review of the literature was conducted guided by the Preferred Reporting Items 
for Systematic Reviews and Meta Analyses statement (Moher, Liberati, Tetzlaff, Altman, & 
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Prisma Group, 2009). An electronic search was conducted using PsychInfo, Medline and 
Web of Science databases from inception to December 31st 2017. 
Search terms were elaborated to improve search strategy (see Appendix A).  Search terms for 
the construct ‘ASD’ were elaborated to include those with a diagnosis of autism/autistic 
disorder (AD), Asperger’s Syndrome (AS), Pervasive Development Disorder (PDD), and 
Pervasive Developmental Disorder – Not otherwise specified (PDD-NOS), as informed by 
Richa, Fahed, Khoury and Mishara (2014), Segers and Rawana (2014), and Zahid and 
Upthegrove (2017). Elaborated search terms for the construct of ‘suicide’ were informed by 
Chan et al.(2016), and Evans et al.(2005). Search terms for constructs of ‘child’ and 
‘adolescent’ were informed by Rosing, Schmidt, Wedderkopp and Baguley (2016) (see 
Figure 1.).   
Inclusion Criteria 
• English Language 
• Peer reviewed journal 
• Quantitative study 
• Suicidality is an outcome variable of interest 
• ASD cohort consisting of people with formal diagnosis of ASD including ASD, AS, 
PDD and PDD-NOS 
• Children and/or adolescents (3-19yo) included in sample – this age range is to reflect 
the depiction within current literature, as well as reflecting the current culture in 
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which 19 years old is a threshold at which young people often transition to adult 
services from children and young people services (NHS England, 2015). 
Exclusion Criteria 
• Qualitative studies 
• Case studies 
• Autism defined solely by measure of autistic traits, without presence/indication of 
formal diagnosis within sample 
• Adult-only samples 
• Books/chapters 
• Evaluation of psychopharmacological intervention 
• Editorials 
Quality of Evidence 
Quality of studies was reviewed using the critical appraisal template for cohort studies, a 
quality assessment tool from the Critical Appraisal Skills Programme (CASP, 2017; see 
Appendix B). Rather than using numerical ratings of study quality, which have been shown to 
have poor validity and reliability (Booth, Sutton, & Papaioannou, 2016), the CASP checklist 
was selected as it provides a clear structure to systematically critique and evaluate quality of 
research studies.   
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Figure 1.  Literature Search Strategy. 
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Literature Review 
Overview of Studies 
The search protocol yielded nine studies which met the inclusion criteria.  Basic study 
information, including demographic and sample information, is presented in Table 1. 
Location.   Of these studies, five were from the United States of America, two from 
Turkey, one from Japan, and the last from Taiwan.  
Setting. Two studies were conducted in hospitals, three conducted in outpatient 
clinics, two via mail and websites, one conducted in a university, and one using a national 
health insurance research database.  Of the two hospital studies, one was conducted in an 
inpatient unit, the other in an advanced critical care centre.  
Design. Seven studies utilised cross-sectional study design.  The remaining two used 
prospective cohort study design, varying in length of study with follow-up periods ranging 
collectively from 1-15 years. 
Suicidality Definition. Studies varied on the aspect of suicidality investigated: four 
studies investigated both suicidal ideation and suicidal attempts, three studies investigated 
suicidal ideation only, and two studies explored suicidal attempt only. 
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Table 1.  Basic Study Information Including Demographic and Sample Information 
Study Purpose Location Design 
Study 
duration 
Setting 
Sample 
Total 
Sample 
size 
ASD Sample Comparison Sample 
Sample 
Characteristics 
Size  
(% of total 
sample) 
ASD 
Diagnosis 
Gender 
(%male) 
Age 
Sample 
Characteristics 
Size  
(% of total 
sample) 
Gender 
(%male) 
Age 
Shtayermman 
(2007) 
To examine the level 
of suicidal ideation 
and co-occurring 
disorders in 
adolescents and 
young adult with 
Asperger's 
syndrome. 
USA Cross-sectional N/A 
Community: self-
administered mail 
questionnaire and 
web-based 
questionnaire 
10 
Adolescents/young 
adults diagnosed with 
AS who had 
participated in a 
previous study. 
10 (100%) Asperger’s 90% 19.7 (3.0) N/A N/A N/A N/A 
Advertised to parents 
of adolescents/young 
adults diagnosed with 
AS on Autism-related 
websites. 
Shtayermman 
(2008) 
To examine the level 
of suicidal ideation 
and co-occurring 
disorders in 
adolescents and 
young adult with 
Asperger's 
syndrome. 
USA Cross-sectional N/A 
Community: self-
administered mail 
questionnaire and 
web-based 
questionnaire 
10 
Adolescents/young 
adults diagnosed with 
AS who had 
participated in a 
previous study. 
10 (100%) Asperger’s 90% 19.7 (3.0) N/A N/A N/A N/A 
Advertised to parents 
of adolescents/young 
adults diagnosed with 
AS on Autism-related 
websites. 
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Study Purpose Location Design 
Study 
duration 
Setting 
Sample 
Total 
Sample 
size 
ASD Sample Comparison Sample 
Sample 
Characteristics 
Size  
(% of total 
sample) 
ASD 
Diagnosis 
Gender 
(%male) 
Age 
Sample 
Characteristics 
Size  
(% of total 
sample) 
Gender 
(%male) 
Age 
Mikami et al. 
(2009) 
To examine the 
frequency and 
clinical features of 
pervasive 
developmental 
disorder relative to 
suicide attempts. 
Japan Cross-sectional N/A 
Hospital: 
advanced critical 
care centre of 
university 
hospital 
94 
Consecutive sample 
of adolescents 
(<20yo) who had 
been hospitalised for 
inpatient treatment 
following suicide 
attempts (i.e. 
intentionally inflicted 
self-injury with 
suicidal ideation) 
between October 
2004 and July 2007. 
12 (12.8%) 
Asperger’s (6) 
 
PDD-NOS (6) 
41.7% 17.1 (1.6) 
Typical 
development 
82 (87.2%) 45.4% 16.9 (1.6) 
Mukaddes & 
Fateh (2010) 
Report on the rates 
of co-occurring 
psychiatric disorders 
in individuals with 
Asperger’s disorder. 
Turkey Cross-sectional 1-5 years 
Clinic: private 
psychiatry clinic 
37 
Children and 
adolescents referred 
to the clinic from 
December 2002 to 
February 2007. 
 
Inclusion criteria: 
• Diagnosis of 
Asperger’s disorder 
according to DSM-IV 
criteria; 
• Full IQ score >89 
on WISC-R 
37 (100%) Asperger’s 86.5% 10.9 (4.5) N/A N/A N/A N/A 
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Study Purpose Location Design 
Study 
duration 
Setting 
Sample 
Total 
Sample 
size 
ASD Sample Comparison Sample 
Sample 
Characteristics 
Size  
(% of total 
sample) 
ASD 
Diagnosis 
Gender 
(%male) 
Age 
Sample 
Characteristics 
Size  
(% of total 
sample) 
Gender 
(%male) 
Age 
Mayes, 
Gorman, 
Hillwig-
Garcia, & 
Syed (2013) 
To examine the 
frequency of 
suicidal ideation and 
suicide attempts in 
children with 
Autism. 
USA Cross-sectional N/A 
Clinic: outpatient 
psychiatric 
diagnostic clinic 
1012 
Children and 
adolescents with 
ASD evaluated in an 
outpatient psychiatric 
diagnostic clinic. 
791 
(78.2%) 
HFA (537) 
 
LFA (254) 
84.1% 6.6 (3.1) 
Non-autistic 
children with 
diagnosis of MDD 
or dysthymic 
disorder. 
35(1.7%) 25.7% 13.0 (2.3) 
Typically 
developed children 
and adolescents 
who had 
participated in a 
previous general 
population 
epidemiologic 
study on the 
prevalence of 
sleep disorders in 
children. 
186(18.4%) 43.5% 8.7 (1.7) 
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Study Purpose Location Design 
Study 
duration 
Setting 
Sample 
Total 
Sample 
size 
ASD Sample Comparison Sample 
Sample 
Characteristics 
Size  
(% of total 
sample) 
ASD 
Diagnosis 
Gender 
(%male) 
Age 
Sample 
Characteristics 
Size  
(% of total 
sample) 
Gender 
(%male) 
Age 
Storch et al. 
(2013) 
To investigate the 
phenomenology and 
clinical correlates of 
suicidal thoughts 
and behaviours in 
you with ASD. 
USA Cross-sectional N/A 
University: 
Department of 
Psychiatry & 
Neuroscience 
Department of 
Paediatrics 
Department of 
Disability and 
Psychoeducationa
l Studies 
102 
Children and 
adolescents with 
ASD diagnoses and 
co-occurring anxiety 
problems. 
 
Exclusion criteria: 
• IQ<70 (9 excluded) 
• Diagnosis of bipolar 
disorder (None 
excluded) 
• Active psychotic 
symptoms (None 
excluded) 
102 
(100%) 
Autism (28) 
 
Asperger’s 
(39) 
 
PDD-NOS 
(35) 
77% 10.55 (2.31) N/A N/A N/A N/A 
Karakoc 
Demirkaya, 
Tutkunkardas, 
& Mukaddes 
(2016) 
To assess the rate of 
suicidality (suicidal 
ideation, behaviours 
and attempts) and 
associated risk 
factors for 
suicidality in high-
functioning ASD. 
Turkey 
Longitudinal: 
Prospective 
Cohort 
1-15 
years 
Clinic: outpatient 
psychiatry clinic 
of university 
hospital 
55 
Children and 
adolescents attending 
the Autism Clinic of 
Child and Adolescent 
Psychiatry 
department of 
university hospital.   
 
Inclusion criteria: 
• capability of 
reading, writing and 
speaking; 
• no intellectual 
disability (IQ>=70)  
• no history of 
chronic neurological 
or physical disorder; 
• presence of data 
about suicidality. 
55 (100%) 
AD (24) 
 
Asperger’s 
(26) 
 
PDD-NOS (5) 
89% 
13.61 
(range: 7-20) 
N/A N/A N/A N/A 
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Study Purpose Location Design 
Study 
duration 
Setting 
Sample 
Total 
Sample 
size 
ASD Sample Comparison Sample 
Sample 
Characteristics 
Size  
(% of total 
sample) 
ASD 
Diagnosis 
Gender 
(%male) 
Age 
Sample 
Characteristics 
Size  
(% of total 
sample) 
Gender 
(%male) 
Age 
Chen et al. 
(2017) 
To investigate the 
risk of suicide 
attempts among 
adolescents and 
young adults with 
ASD, and the roles 
of co-occurring 
psychiatric disorders 
as potential risk 
factors. 
Taiwan 
Longitudinal: 
Prospective 
Cohort 
2-10 
years 
Population: 
National Health 
Insurance 
Research 
Database 
28090 
ASD cohort: 
adolescents and 
young adults 
diagnosed with ASD 
between January 1st 
2001 and December 
31st 2009 with no 
history of suicide 
attempt prior to 
diagnosis. 
5618 
(20%) 
ASD 78.2% 
 17.2 (4.58); 
Adolescents 
(range: 12-
17), young 
adults 
(range: 18-
29) 
Matched controls: 
adolescents & 
young adults 
without ASD 
diagnosis, and no 
previous history of 
suicide attempt. 
22472 (80%) 78.2% 
 17.2 (4.58); 
Adolescents 
(range: 12-17), 
young adults 
(range: 18-29) 
Horowitz et al. 
(2017) 
To examine the 
prevalence of 
thoughts of death or 
suicide in youth with 
ASD and associated 
co-occurring 
psychiatric 
diagnoses.   
USA Cross-sectional N/A 
Hospital: 
Specialised 
inpatient 
psychiatric units 
107 
Children and 
adolescents with 
ASD diagnosis 
admitted specialized 
inpatient psychiatry 
units for youth with 
ASD and other 
developmental 
disorders. 
 
Inclusion criteria: 
• 10yo or older 
• Non-verbal IQ of 55 
or greater 
• Parent response on 
CASI question about 
suicidal ideation 
 
Exclusion criteria:  
• caregiver lack of 
proficiency in 
English 
• youth having 
prisoner status 
107 
(100%) 
ASD 77% 13.63(2.26) N/A N/A N/A N/A 
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Demographics.  The majority of participants with ASD were male (88.1%).  The 
average age was 14.33 years (range = 1-29).  However, sample composition varied greatly: 
five studies used a mix of child and adolescent participants (1-19 years), three had combined 
samples of adolescents and young adults (12-29 years), and one had adolescent participants 
only (<20 years).  
ASD Diagnosis. Samples consisted of a variety of diagnostic labels: autistic disorder 
(0.77%), Asperger’s Syndrome (1.90%), PDD-NOS (0.68%), ASD (84.92%), high 
functioning autism (HFA; 7.96%), low functioning autism (LFA; 3.77%).  The range of ASD 
diagnoses characterising the samples varied between studies.  Three studies investigated 
cohorts with diagnoses of AS only, and two had cohorts composed only of those with a 
diagnosis of ASD.  Of the remaining five studies, four studied samples composed of multiple 
ASD diagnoses, with two studies using samples with combined compositions of participants 
with diagnoses of AD, AS and PDD-NOS, one study dividing the cohort by level of 
functioning (High-Functioning Autism vs. Low-Functioning Autism), and one study using a 
sample consisting of participants with diagnoses of AS and PDD-NOS. Only two papers 
included external controls as part of their study: one study included both a group of children 
with depression and a typically-developed group with no identified psychological disorders, 
whilst the second study used matched-controls based on age, sex, and date of enrolment into 
study which was defined by date of ASD diagnosis of ASD participant. 
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ASD Measures. A range of measures to assess ASD were used. Three studies used 
diagnostic assessment instruments, two used measures to assess ASD severity only, three 
used clinical interview based on approved diagnostic criteria, and one study used both clinical 
interview and a measure of ASD severity.  No study using clinical interview reported whether 
they used validated diagnostic instruments, or whether assessment was based on the clinical 
judgement of the assessor. 
Suicidality measures. Only three studies administered measures specifically 
designed to assess suicidality, completed by the young people themselves.  Of the remaining 
six studies, three studies utilised measures of psychological difficulties including a 
component assessing suicidality, two assessed via clinical interview, and one reviewed 
patient records.  Of the three studies using measures of psychological difficulties, no study 
used young person report only: one study used report from the young person as well as the 
parent, whilst the other two relied solely on parental ratings.  
Psychological Disorder Assessment Measures. Seven studies used standardised 
measures to assess for depression and other co-occurring psychological disorders: of these 
studies, two studies used parental report only, two studies used only young person report, and 
three administered to both parent and young person.  The two remaining studies used clinical 
interview guided by diagnostic criteria.  
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Study focus.   Of the nine papers, four investigated prevalence and incidence of 
suicidality only, with three examining rates of suicidality within the ASD cohort, and one 
investigating rates of ASD in a suicidal cohort.  All four studies investigated prevalence of 
co-occurring psychological disorders, with two also including peer victimisation as a variable 
of interest.  The remaining five studies, alongside examining prevalence, investigated 
potential psychological and demographic risk factors for suicidality in ASD samples: four 
examined predictors of reporting suicidality, the remaining study investigating predictors of 
subsequent suicide attempt.  Of these five, three investigated differences in suicidality 
presentation (i.e. ideation vs behaviours/attempts); however, only one investigated the 
relationship between potential risk factors and each individual suicidal presentation. 
Statistical analysis. Statistical analyses employed varied between papers.  One study 
reported descriptive statistics only, and three studies reported significance of association 
between factors and outcome variable.  The remaining five tested for strength of association 
alongside significance, of which two used correlational analysis, one used odds ratios (OR), 
another Cohen’s d and explained variance, and the last used hazard ratios (HR). 
Repeated testing. Two studies analysed participants from the same cohort 
(Shtayermman, 2007; 2008); however, whilst there is overlap in variables, there are also 
factors unique to each paper. Therefore, duplicated analyses have been condensed and will be 
reported as a single finding. 
Overview of Findings 
An overview of findings around prevalence of suicidality and risk factors is presented in 
Table 2. 
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Prevalence of Suicidality in ASD  
Eight papers reported prevalence of suicidality in ASD, of which two examined suicidal 
ideation and suicide attempt as separate outcome variables.  According to Mayes, Gorman, 
Hillwig-Garcia, and Syed (2013), mothers of children with ASD reported rates of suicidal 
ideation and suicide attempt of 10.9% and 7.2%, respectively.  Karakoc Demirkaya, 
Tutkunkardas, and Mukaddes (2016) found within their sample 16.3% reporting suicidal 
ideation, and 12.7% having attempted suicide.   
Three studies examined suicidal ideation only within ASD.  Shtayermann (2007; 2008) found 
50% of its sample experienced suicidal ideation.  Horowitz et al. (2017) found 22.4% of 
youth with ASD in a psychiatric inpatient unit reported by their parent/guardian to have 
periods of frequently talking about suicide or death. 
Chen et al. (2017) examined only suicide attempt in ASD, finding 3.9% of their ASD cohort 
had attempted suicide during the course of the study. 
The remaining two papers examined ideation and attempt combined into a single outcome 
variable.  Mukaddes and Fateh (2010) found 16% of their sample of youth diagnosed with 
Asperger’s reported a history of suicidality.  Storch et al. (2013) reported 20% of their 
participants disclosed either having suicidal thoughts, thinking a lot about death/dying, or a 
history of suicide attempt; furthermore, suicidality was observed in 11% of their sample, 
determined by endorsement of questionnaire items measuring suicidal thoughts, suicide 
planning, or previous suicide attempts. 
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Table 2.  Overview of findings:  Suicidality, ASD and associated factors 
Study 
Suicidality 
investigated 
Data Sources 
Measures for 
Suicidality 
Measures 
for ASD 
Measure for 
psychological 
disorders 
Other measures/data 
collected 
Data 
analysis 
Prevalence of 
suicidality in 
ASD sample 
Prevalence 
of ASD in 
suicidal 
sample 
Psychological 
Disorders 
identified in 
study 
Rates of 
Psychological 
disorders in 
ASD suicidal 
sample 
Rates of 
Psychological 
disorders 
identified in 
ASD sample 
Findings 
Suicidality 
Psychological 
Disorders 
Socio-
Demographic 
Factors 
Shtayermman 
(2007) 
Suicidal 
ideation 
Questionnaires 
(young person) 
Suicidal 
Ideation 
Questionnaire 
KADI PHQ-A 
Peer victimization 
(SEQ) 
Correlational 
analysis 
50.0% N/A 
• MDD  
• GAD  
• Additional 
psychiatric 
diagnoses 
(bipolar 
disorder, OCD) 
Not reported 
• MDD (20%) 
• GAD (30%) 
• Additional 
psychiatric 
diagnoses 
(bipolar 
disorder, OCD) 
(67%) 
50% 
reported 
suicidal 
ideation.  
Significant negative 
correlation between 
level of suicidal 
ideation and severity 
of AS presentation. 
38% reported 
experiencing 
peer 
victimisatin 
Current age, age at 
first diagnosis, 
professional who 
gave AS diagnosis, 
additional 
psychiatric 
diagnoses, whether 
AS was first 
diagnosis given, 
medication status, 
number of services 
received, 
educational setting, 
highest level of 
education, living 
situation, 
employment status, 
number of hours a 
week worked at 
paying in job in the 
last month, does 
volunteer work, 
number of hours a 
week of volunteer 
activity in past 
month amongst 
those who volunteer 
20% met criteria for 
MDD.  
(21.4% reported 
depressive symptoms) 
30% met criteria for 
GAD. 
(21.4% reported 
anxiety symptoms) 
Positive but 
not significant 
correlation 
between level 
of suicidal 
ideation and 
level of peer 
victimisation. 
Positive but not 
significant correlations 
between level of 
suicidal ideation and 
level of anxiety 
symptoms, depressive 
symptoms. 
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Study 
Suicidality 
investigated 
Data Sources 
Measures for 
Suicidality 
Measures 
for ASD 
Measure for 
psychological 
disorders 
Other measures/data 
collected 
Data 
analysis 
Prevalence of 
suicidality in 
ASD sample 
Prevalence 
of ASD in 
suicidal 
sample 
Psychological 
Disorders 
identified in 
study 
Rates of 
Psychological 
disorders in 
ASD suicidal 
sample 
Rates of 
Psychological 
disorders 
identified in 
ASD sample 
Findings 
Suicidality 
Psychological 
Disorders 
Socio-
Demographic 
Factors 
Shtayermman 
(2008) 
Suicidal 
ideation 
YP Questionnaires 
Suicidal 
Ideation 
Questionnaire 
KADI PHQ-A 
Current age, age at 
first diagnosis, 
professional who 
gave AS diagnosis, 
additional 
psychiatric 
diagnoses, whether 
AS was first 
diagnosis given, 
medication status, 
number of services 
received, 
educational setting, 
highest level of 
education, living 
situation, 
employment status, 
number of hours a 
week worked at 
paying in job in the 
last month, does 
volunteer work, 
number of hours a 
week of volunteer 
activity in past 
month amongst 
those who volunteer 
Correlational 
analysis 
50.0% N/A 
• MDD  
• GAD  
• Additional 
psychiatric 
diagnoses 
(bipolar 
disorder, OCD) 
Not reported 
• MDD (20%) 
• GAD (30%) 
• Additional 
psychiatric 
diagnoses 
(bipolar 
disorder, OCD) 
(67%) 
50% 
reported 
suicidal 
ideation.  
Significant negative 
correlation between 
level of suicidal 
ideation and severity 
of AS presentation. 
  
20% met criteria for 
MDD.  
(21.4% reported 
depressive symptoms) 
30% met criteria for 
GAD. 
(21.4% reported 
anxiety symptoms) 
Positive but not 
significant correlations 
between level of 
suicidal ideation and 
level of anxiety 
symptoms, depressive 
symptoms. 
Mikami et al 
(2009) 
Suicide 
Attempt: 
Emergency 
room patients 
who inflicted 
serious self-
harm with 
suicidal 
ideation. 
Hospital records 
Psychiatric 
interview 
based on 
DSM-IV-TR 
criteria 
Clinical 
judgement 
on basis of 
DSM-IV-
TR criteria 
 
AQ-J 
Clinical 
judgement on 
basis of 
DSM-IV-TR 
criteria 
IQ (WAIS-R; 
WISC-III) 
chi-square/ 
Fisher's 
Exact tests; 
Mann-
Whitney U 
test 
100.0% 12.8% 
• Mood disorder 
• Anxiety 
disorder  
• Adjustment 
disorder  
• Mood disorder 
(8.3%) 
• Anxiety 
disorder (8.3%)  
• Adjustment 
disorder (83%) 
N/A   
12.8% individuals 
diagnosed with PDD 
(PDD-NOS=6; AS=6). 
  
Method of 
attempted suicide: 
overdose, jumping, 
hanging, stabbing, 
poisoning, carbon 
monoxide poisoning 
Participants with PDD 
were significantly less 
likely to have a mood 
disorder or anxiety 
disorder than non-
PDD participants. 
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Study 
Suicidality 
investigated 
Data Sources 
Measures for 
Suicidality 
Measures 
for ASD 
Measure for 
psychological 
disorders 
Other measures/data 
collected 
Data 
analysis 
Prevalence of 
suicidality in 
ASD sample 
Prevalence 
of ASD in 
suicidal 
sample 
Psychological 
Disorders 
identified in 
study 
Rates of 
Psychological 
disorders in 
ASD suicidal 
sample 
Rates of 
Psychological 
disorders 
identified in 
ASD sample 
Findings 
Suicidality 
Psychological 
Disorders 
Socio-
Demographic 
Factors 
Mukaddes & 
Fateh (2010) 
Suicidal 
behaviours 
(ideation, 
attempt) 
Child 
assessment/interview 
 
Parent 
assessment/interview 
Clinical 
interviews of 
patients & 
their parents. 
Clinical 
judgment 
and 
diagnostic 
interview 
in 
accordance 
with 
DSM-IV 
criteria 
K-SADS-PL 
Clinical 
assessment 
using DSM-
IV criteria 
WISC-R 
Descriptive 
(frequency) 
16% total 
sample (42% 
of 
adolescents 
age 12–20; 
0% in 
children) 
N/A 
• Anxiety 
Disorders (OCD, 
specific phobia)  
• Mood 
disorders (MDD, 
BP), 
• Disruptive 
Behaviour 
disorders 
(ADHD, ODD, 
CD) 
• Tic Disorders 
MDD only 
(100%) 
• Anxiety 
Disorders 
(OCD, specific 
phobia; 54%) 
• Disruptive 
Behaviour 
disorders 
(ADHD, ODD, 
CD; 48%) 
• Mood 
disorders (MDD 
and BP; 37%) 
• Tic Disorders 
(18%) 
16% 
reported 
suicidality. 
All patients reporting 
suicidal ideation or 
behaviours met DSM 
criteria for major 
depressive disorder. 
All patients 
reporting 
suicidal 
ideation or 
behaviours 
were 
adolescents 
(12-20 years). 
Age, gender, 
developmental 
history 
Mayes, 
Gorman, 
Hillwig-
Garcia, & 
Syed (2013) 
Suicidal 
ideation 
(“talks about 
harm or 
killing self”); 
Suicide 
attempts 
(“deliberately 
harms oneself 
or attempts 
suicide”) 
Parent 
assessment/interview 
Pediatric 
Behavior 
Scale (rated 
by mothers) 
CASD 
Pediatric 
Behavior 
Scale 
Demographics, 
parental 
occupation/socio-
economic status 
Chi-square 
test; Cohen's 
d/ 
explained 
variance; 
stepwise 
binary 
logistic 
regression  
13.8% 
(suicide 
attempt: 
7.2%; 
suicidal 
ideation: 
10.9%) 
82% 
• MDD  
• Behaviour 
problems  
• Mood 
dysregulation  
• Impulsive  
• Anxiety  
• Somatic 
complaints  
• Sleep 
disturbance  
• MDD (26.4%)  
• Behaviour 
problems 
(23.5%)  
• Mood 
dysregulation 
(19.6%)  
• Impulsive 
(15.7%)  
• Anxiety 
(18.2%)  
• Somatic 
complaints 
(29.5%)  
• Sleep 
disturbance 
(18.6%) 
• MDD (40.2%)  
• Behaviour 
problems 
(41.0%)  
• Mood 
dysregulation 
(65.1%)  
• Impulsive 
(87.6%)  
• Anxiety 
(66.8%)  
• Somatic 
complaints 
(14.2%)  
• Sleep 
disturbance 
(44.8%) 
13.8% 
reported 
suicidality:  
 
• 10.9% 
reported 
suicidal 
ideation  
• 7.2% 
reported 
attempts 
Psychological 
predictors of suicidal 
ideation or behaviour 
in children with 
autism:  
 
• Depression 
• Behaviour problems 
(oppositional, 
aggressive, angry, 
explosive,impulsive) 
• Bullied by peers 
Demographic 
predictors of 
suicide 
behaviour in 
children with 
autism:  
 
• Male 
• 10yo or older 
• Black or 
Hispanic 
• Lower SES 
Suicide 
behaviour 
(ideation 
or 
attempts) 
in children 
with 
autism 
was 28 
more 
times 
more 
common 
than in 
typical 
children, 
but less 
than 
depressed 
sample. 
Protective 
psychological factors 
against suicidal 
ideation or behaviour 
in children with 
autism: 
• no impulsiveness 
• no mood 
dysregulation 
• no behaviour 
problems 
Protective 
demographic 
factors against 
suicidal 
ideation or 
behaviour in 
children with 
autism: 
• Female 
• White/Asian 
• Higher SES 
• Younger than 
10 years; 
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Study 
Suicidality 
investigated 
Data Sources 
Measures for 
Suicidality 
Measures 
for ASD 
Measure for 
psychological 
disorders 
Other measures/data 
collected 
Data 
analysis 
Prevalence of 
suicidality in 
ASD sample 
Prevalence 
of ASD in 
suicidal 
sample 
Psychological 
Disorders 
identified in 
study 
Rates of 
Psychological 
disorders in 
ASD suicidal 
sample 
Rates of 
Psychological 
disorders 
identified in 
ASD sample 
Findings 
Suicidality 
Psychological 
Disorders 
Socio-
Demographic 
Factors 
Storch et al 
(2013) 
Suicidal 
Ideation 
(“thoughts of 
death or 
dying”; 
“thought 
about killing 
him/herself”; 
“thought of a 
way to kill 
him/herself”); 
Suicide 
attempt 
(“tried to kill 
him/herself”) 
Child 
assessment/interview 
 
Parent 
assessment/interview 
Anxiety 
Disorder 
Interview 
Schedule - 
Child and 
Parent 
Versions 
ADOS; 
ADI-R 
ADIS-IV-CP; 
PARS; 
CBCL; 
MASC-P; 
CIS-PV 
Demographics, 
medication status  
Chi-square 
tests; 
Cramers V; 
Cohen's d; 
Kruskal-
Wallis test; 
Mann-
Whitney 
tests; 
Logistic 
Regression 
11.0% N/A 
• Social phobia  
• GAD  
• Specific phobia  
• DBD  
• Separation 
anxiety disorder  
• OCD  
• 
MDD/dysthymia  
• PTSD  
• Social phobia 
(100%) 
• GAD (90.9%) 
• Specific 
phobia (72.7%) 
• DBD (63.6%) 
• Separation 
anxiety disorder 
(27.3%) 
• OCD (54.5%) 
• 
MDD/dysthymia 
(36.4%) 
• PTSD (27.3%) 
• Social phobia 
(86.3%) 
• GAD (74.5%) 
• Specific 
phobia (62.7%) 
• DBD (56.8%) 
• Separation 
anxiety disorder 
(41.2%) 
• OCD (35.2%) 
• 
MDD/dysthymia 
(13.7%) 
• PTSD (5.8%) 
11% 
reported 
suicidality. 
Children with autism 
are more likely to have 
suicidal 
thoughts/behaviors 
than those with 
Asperger’s disorder. 
  
Suicidality predicted 
when presence of co-
occurring diagnosis of 
• Depression 
• PTSD 
Demirkaya, 
Tutkunkardas, 
& Mukaddes 
(2016) 
Suicidal 
Ideation; 
Suicide 
Attempt 
Child 
assessment/interview 
 
Parent 
assessment/interview 
Eskin's 
Suicide 
Screening 
Questionnaire 
Clinical 
judgement 
on basis of 
DSM-IV-
TR criteria 
K-SADS-PL 
Sociodemographic 
data form: detailed 
developmental 
history, history of 
behavioral, 
emotional and 
physical problems, 
detailed medical 
history (drugs, co-
occurring diseases, 
hospitalizations, 
emergency visits), 
family history of 
suicidal behaviors 
and attempts, 
alcohol-substance 
use disorder, other 
psychiatric 
disorders, 
aggressive 
behaviors of the 
patients toward 
others and self 
Chi-square 
tests: 
Pearson, 
Fisher's 
Exact, 
McNemar 
29% 
(ASD:43.8%; 
AS:50%; 
PDD-
NOS:6.2%) 
N/A 
• Depression 
• Bipolar 
disorder 
• GAD 
• Separation 
Anxiety disorder 
• OCD 
• Social Phobia 
• Specific phobia 
• ADHD 
• Psychotic 
features 
• Depression 
(18.7%) 
• Bipolar 
disorder (12.5%) 
• GAD (6.2%) 
• Separation 
Anxiety disorder 
(0%) 
• OCD (12.5%) 
• Social Phobia 
(6.2%) 
• Specific 
phobia (6.2%) 
• ADHD (50%) 
• Psychotic 
features (25%) 
• Depression 
(18.1%) 
• Bipolar 
disorder (5.4%) 
• GAD (5.4%) 
• Separation 
Anxiety disorder 
(1.8%) 
• OCD (18.1%) 
• Social Phobia 
(5.4%) 
• Specific 
phobia (7.2%) 
• ADHD 
(65.5%) 
• Psychotic 
features (9.1%) 
29% 
reported 
suicide: 
 
• ASD 
(43.8%)  
• AS 
(50%) 
• PDD-
NOS 
(6.2%) 
Suicidality associated 
with presence of 
psychotic features 
Suicidality 
associated with 
presence of 
family history 
of completed 
suicide 
Psychological 
disorders identified: 
 
• mood disorders 
(23.6%) 
• anxiety disorders 
(43.6%) 
• disruptive behaviours 
(65.4%) 
Suicidality 
associated with 
presence of 
family history 
of lethal and 
nonlethal 
suicidal 
behaviours 
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Study 
Suicidality 
investigated 
Data Sources 
Measures for 
Suicidality 
Measures 
for ASD 
Measure for 
psychological 
disorders 
Other measures/data 
collected 
Data 
analysis 
Prevalence of 
suicidality in 
ASD sample 
Prevalence 
of ASD in 
suicidal 
sample 
Psychological 
Disorders 
identified in 
study 
Rates of 
Psychological 
disorders in 
ASD suicidal 
sample 
Rates of 
Psychological 
disorders 
identified in 
ASD sample 
Findings 
Suicidality 
Psychological 
Disorders 
Socio-
Demographic 
Factors 
Chen et al 
(2017) 
Suicide 
Attempt (as 
coded by 
emergency 
room 
physicians, 
psychiatrists, 
internal 
medicine, and 
surgeons) 
National Health 
Insurance Research 
Database (NHIRD) 
Patient 
records 
Clinical 
judgment 
and 
diagnostic 
interview 
Clinical 
judgment and 
diagnostic 
interview 
Demographics, age 
at first suicide 
attempt, time 
between ASD 
diagnosis and first 
suicide attempt, 
level of 
urbanisation, 
income-related 
insured amount 
t-tests; 
Pearson chi-
squared; 
Cox 
regression 
models; 
sensitivity 
analysis 
3.9% 58.7% 
• Unipolar 
Depression  
• Bipolar 
disorder 
• Anxiety 
disorders 
• ADHD 
• Disruptive 
behaviour 
disorders 
• Alcohol use 
disorder 
• Substance use 
disorder 
• Intelligence 
disability 
Not reported 
• Unipolar 
Depression 
(16.0%) 
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(11.2%) 
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3.9% 
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• ADHD 
• DBD 
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factor for suicide 
attempts amongst both 
adolescents and adults. 
Increased probability 
of suicidality across 
total adolescent 
sample associated 
with: 
 
• Unipolar Depression 
• Substance use 
disorder 
Substance use disorder 
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disorder increase 
likelihood of 
suicidality in males 
only. 
Horowitz et al 
(2017) 
Suicidal 
ideation 
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Child and 
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(parent 
rating) 
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Spearman 
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analysis; 
Ordered 
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models 
22.4% N/A 
• Mood disorder 
• Anxiety 
disorder 
• DBD 
• ADHD 
• Mood disorder 
(42%)* 
• Anxiety 
disorder (58%)* 
• DBD (33%)  
• ADHD (29%)* 
• Mood disorder 
(29%) 
• Anxiety 
disorder (42%) 
• DBD (39%) 
• ADHD (40%) 
22.4% 
reported 
talking 
about 
death or 
suicide. 
Increased likelihood of 
talking about death or 
suicide associated 
with: 
 
• Mood disorder  
• Anxiety disorder 
  
Demographics, non-
verbal IQ (NVIQ) 
Reduced likelihood of 
talking about death or 
suicide associated with 
ADHD. 
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Mikami et al. (2009) was the only study to report method of attempt within their ASD 
sample.  They found subjects engaged in drug overdose (58.3%), jumping (25%), carbon 
monoxide poisoning (8.35%), and poisoning (8.35%).  
Two studies compared suicidality prevalence between ASD and typically-developed controls.  
Mayes et al. (2013) found that rates of suicidal ideation or suicide attempt in children with 
ASD was 28 times greater than in typically-developing controls, but three times less frequent 
than in the depressed sample.  Similarly, Chen et al. (2017) reported that adolescents and 
young adults with ASD were five times more likely to attempt suicide in later life compared 
to non-autistic controls. 
Prevalence of ASD in Suicidality 
Three studies investigated percentage of ASD diagnoses within the larger sample of youth 
presenting with suicidality; however, rates varied greatly.  Mikami et al. (2009) reported 
12.8% of their suicidal sample was diagnosed with ASD; in contrast, both Mayes et al. (2013) 
and Chen et al. (2017) reported much higher rates of 82% and 58.7% of their respective 
suicidal samples having a diagnosis of ASD. It should be noted that the high rate of ASD 
within suicidal sample reported by Mayes et al. (2013) may not be representative, as their 
ASD sample made up 78.2% of their entire sample; however, rates reported in the other two 
papers evidence that youth with ASD make up a significant fraction of the overall sample of 
suicidal youth (Chen et al., 2017; Mikami et al., 2009). 
Prevalence of Psychological Disorders in ASD  
All papers reported prevalence of psychological disorders.  Six papers reported rates 
specifically within suicidal contingent of their ASD cohort; however, specific individual 
disorders investigated varied greatly amongst studies.  Depression was most commonly 
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included, with four papers reporting rates ranging from 18.7% to 100% (Karakoc Demirkaya 
et al., 2016; Mayes et al., 2013; Mukaddes & Fateh, 2010; Storch et al., 2013), followed by 
anxiety, reported in three papers rates ranging from 6.2% to 90.9% (Karakoc Demirkaya et 
al., 2016; Mayes et al., 2013; Storch et al., 2013). Two studies (Karakoc Demirkaya et al., 
2016; Storch et al., 2013) reported prevalence of: social phobia 6.2%-100%; separation 
anxiety 0%-27.3% ; specific phobia 6.2%-72.7%(Karakoc Demirkaya et al., 2016; Storch et 
al., 2013); OCD 12.5%-54.5% (Karakoc Demirkaya et al., 2016; Storch et al., 2013) . No 
more than two studies reported prevalence of:  ADHD 29%-50% (Horowitz et al., 2017; 
Karakoc Demirkaya et al., 2016); DBD 33%-63.6% (Horowitz et al., 2017; Storch et al., 
2013). 
There were four studies which were sole investigators of specific presentations.  Mayes et al. 
(2013) was the only study to report rates of sleep disturbance (18.6%), somatic complaints 
(29.5%), mood dysregulation (19.6%), and impulsivity (15.7%).  Mikami et al. (2009) 
reported 83% having a diagnosis of adjustment disorder, whilst Storch et al. (2013) found that 
27.3% had a diagnosis of PTSD. Karakoc Demirkaya et al. (2016) found 25% of their 
suicidal sample reported having psychotic experiences, and 12.5% had a diagnosis of bipolar 
disorder.  Two studies (Horowitz et al., 2017; Mikami et al., 2009) used umbrella terms 
grouping together multiple diagnoses: “anxiety disorders” (phobias, separation anxiety, 
generalized anxiety, Post-traumatic Stress Disorder; PTSD), ranging from 8.3% to 58%, and 
“mood disorders” (Bipolar disorder, Major Depressive Disorder), ranging from 8.3% to 42%. 
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Risk Factors Associated with Suicidality In ASD 
ASD Presentation. Five papers compared the relationship between suicidality and 
different ASD presentations.  Shtayermann (2007; 2008) looked at level of AS traits, finding 
that suicidal ideation was negatively correlated with ratings of severity of AS presentation. Of 
the three papers which compared rates of suicidality between different ASD diagnoses 
(Karakoc Demirkaya et al., 2016; Mayes et al., 2013; Storch et al., 2013) only one reported 
significant results. Storch et al. (2013) found that children with Autism were more likely to 
report suicidal ideation or attempt than those with Asperger’s Syndrome. 
Suicidal Ideation. Mayes et al. (2013) were the only researchers to investigate the 
relationship between different phenomena of suicidality.  Investigating suicidal ideation as a 
potential risk factor for suicidal attempt, when entered into a stepwise linear regression 
analysis with multiple demographic and co-occurring psychological factors, suicidal ideation 
emerged as the strongest single predictor of suicidal attempt. 
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Psychological Disorder Diagnosis. Six studies reported on the role of depression 
within suicidality (Chen et al., 2017; Mayes et al., 2013; Mukaddes & Fateh, 2010; 
Shtayermman, 2007; Shtayermman, 2008; Storch et al., 2013), of which four reported 
significant results. Mukaddes and Fateh (2010), the only study not involving statistical tests, 
reported frequency only, but found that all participants reporting suicidality had a co-
occurring diagnosis of MDD.  Of the five papers that employed significance testing, three 
reported significant positive associations.  Mayes et al. (2013) found depression not only to 
be a significant risk factor for suicidal ideation or attempt in children with autism but was 
also the strongest single predictor of suicidal ideation in their sample; similarly, Storch et al. 
(2013) reported that suicidal thoughts and behaviours were associated with depression. Chen 
et al. (2017), the only study to investigate the temporal relationship between suicidality and 
depression, found that unipolar depression was associated with increased probability of 
suicidality across both the total adolescent sample, and the sample as a whole.  Shtayermann 
(2007; 2008) reported positive correlations between level of suicidal ideation and depressive 
symptoms, but these were not statistically significant.  
Of the six studies reporting on the role of anxiety in the suicidality phenomena (Karakoc 
Demirkaya et al., 2016; Mayes et al., 2013; Mukaddes & Fateh, 2010; Shtayermman, 2007; 
Shtayermman, 2008; Storch et al., 2013), there was no significant association discovered. 
Shtayermann (2007; 2008) reported positive correlations between level of suicidal ideation 
and anxiety symptoms, but again these were not statistically significant. 
Storch et al. (2013) was the only paper to investigate PTSD as a risk factor for suicidality, 
reporting suicidal thoughts and behaviours to be associated with PTSD.  
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Of the four studies including ADHD within their analysis (Chen et al., 2017; Horowitz et al., 
2017; Karakoc Demirkaya et al., 2016; Mukaddes & Fateh, 2010) one study reported 
significant results: Horowitz et al. (2017) found that ADHD was negatively associated with 
talking about death or suicide within their sample. 
There were several studies that were sole investigators of specific psychological disorders 
and phenomena.  Mukaddes and Fateh (2010) was the only study reporting on Oppositional 
Defiant Disorder within their sample but found that none of the suicidal individuals met 
criteria for said diagnosis.   
Karakoc Demirkaya et al. (2016) was the only study to examine psychotic features as a 
potential risk factor, finding suicidality to be positively associated with the presence of 
psychotic features; they were also the only study to include bipolar disorder in their analysis, 
but this was not found to be significant.  
Mayes et al. (2013) were the investigators of the role of different behavioural profiles as risk 
factors, finding that behavioural problems (oppositional, aggressive, angry, explosive, 
impulsive) were risk factors for suicidal ideation or attempt.  Furthermore, before suicidal 
ideation, mood dysregulation was the stronger predictor of suicidal attempt. 
Chen et al. (2017) investigated the relationship between suicidality and both substance-use 
disorder and alcohol-use disorder, reporting an increased likelihood of subsequent suicide 
attempt in males associated with both disorders; however, it should be noted that this is in 
reference to the entire sample, and not the ASD cohort specifically.  
Two studies used the umbrella term “mood disorders” to refer to multiple different diagnoses, 
with one study investigating its role as a risk factor (Horowitz et al., 2017), the other 
comparing rates with non-ASD controls (Mikami et al., 2009). Horowitz et al. (2017), the 
Running head: SUICIDALITY RISK FACTORS ADOLESCENTS WITH ASD 
32 
 
only study to define the diagnoses included under this label (Bipolar 1, Unspecified Bipolar, 
Major Depressive Disorder, Unspecified Depression), found mood disorders to be positively 
associate with talking about death or suicide.  Mikami et al. (2009) reported that there were 
significantly lower rates of mood disorders in their PDD group than the non-PDD controls; 
however, the size of the PDD cohort was a quarter of that of the comparison group, so the 
fact that the groups were unbalanced may have had an impact on the results and should 
therefore be held in mind before drawing any definitive conclusions about differences 
between ASD and non-ASD populations. 
Three studies used the umbrella term “anxiety disorders” to refer to multiple different 
diagnoses: two studies investigating its role as a risk factor (Chen et al., 2017; Horowitz et 
al., 2017), the other comparing rates with non-ASD controls (Mikami et al., 2009). Of the 
two investigating risk factors, only Horowitz et al. (2017), the only study to define the 
diagnoses included under this label (phobias, separation anxiety, generalized anxiety, Post-
traumatic Stress Disorder), found anxiety disorders to be positively associate with talking 
about death or suicide. Mikami et al. (2009) reported that there were significantly lower rates 
of anxiety disorders in their PDD group than the non-PDD controls: once again, given the 
unbalanced group sizes, one should be cautious before drawing any definitive conclusions 
about differences between ASD and non-ASD populations. 
Socio-Demographic characteristics. Mayes et al. (2013) was the only paper to 
examine gender, finding that being male was a significant predictor of suicidal ideation or 
attempt.  
Two studies reported on the relationship between suicidality and age (Mayes et al., 2013; 
Mukaddes & Fateh, 2010). Mukaddes and Fateh (2010) reported that all participants who had 
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reported suicidality were in adolescence (12-20 years).  Mayes et al. (2013), the only study of 
the two to analyse the relationships statistically, found that being 10 years old or older was a 
predictor of suicidal ideation or attempt.  Mayes et al. (2013) also looked at ethnicity and 
socioeconomic status (SES), reporting that being, black, Hispanic, and from a lower SES 
were predictors of suicidality. 
The only study to examine family characteristics, Karakoc Demirkaya et al. (2016) reported 
suicidality to be associated with both family history of lethal and nonlethal suicidal 
behaviours, and familial history of completed suicide. 
Both Mikami et al. (2009) and Mayes et al. (2013) reported significant associations between 
suicidality and factors pertaining to social relationships. Mikami et al. (2009), found that 75% 
of PDD group reported personal relationship conflict, such as being bullied, to be the 
precipitating event of suicide attempts; similarly, Mayes et al. (2013) reported being teased as 
a significant risk factor for suicidality within their sample. 
Protective factors in ASD 
Mayes et al. (2013) was the only study to highlight factors associated with significantly lower 
likelihood of suicidality, identifying a combination of demographic and psychological 
factors.  They found that participants who were female, white, Asian, and from a higher 
socio-economic status reported no instances of suicidality; furthermore, children reported not 
to display any mood dysregulation, behavioural problems, or impulsivity significantly less 
likely to display any type of suicidality. 
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Methodological Issues 
Design. Seven studies utilised cross-sectional designs (Horowitz et al., 2017; Mayes 
et al., 2013; Mikami et al., 2009; Mukaddes & Fateh, 2010; Shtayermman, 2007; 
Shtayermman, 2008; Storch et al., 2013), which can be effective in both determining 
prevalence of an outcome, and identifying significant associations between factors and 
outcomes. However, a disadvantage of this design is that one cannot infer causality between 
factors and outcomes; therefore, it can only be concluded that a given factor is significantly 
associated with the presence of suicidality, giving no indication of whether it preceded 
suicidality as a potential cause/contributing factor. 
The remaining two studies used prospective longitudinal designs (Chen et al., 2017; Karakoc 
Demirkaya et al., 2016), which unlike cross-sectional studies, allows for clearer 
understanding of the direction of the temporal relationship between risk factors and 
suicidality i.e. assessing whether a risk factor preceded suicidality; however only Chen et al. 
(2017) conducted analysis investigating the temporal relationship between risk factors and 
subsequent suicide attempt. However, a disadvantage of this design is that, due to its 
observational approach, it is difficult to control for potential confounding variables.  Chen et 
al. (2017) sought to account for this by including matched controls as their comparison 
group; whilst this can help control for confounding variables, it risks selection bias, resulting 
in controls not being representative of the general population.  
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Sample size. Six studies boasted large sample sizes (Chen et al., 2017; Horowitz et 
al., 2017; Karakoc Demirkaya et al., 2016; Mayes et al., 2013; Storch et al., 2013), an 
advantage of which is that larger sample sizes increase the power of statistical tests in 
detecting significant differences, reducing the probability of wrongly rejecting the research 
hypothesis. The smaller sample sizes reported in the remaining four papers (Mikami et al., 
2009; Mukaddes & Fateh, 2010; Shtayermman, 2007; 2008) mean that the statistical power 
of the analyses was diminished, therefore making it difficult to test associations and draw 
conclusions with confidence: three studies acknowledge this limitation (Mikami et al., 2009; 
Mukaddes & Fateh, 2010; Shtayermman, 2007). Whilst large sample sizes can improve the 
probability of detecting statistically significant differences, they offer little information on 
practical or clinical significance of observed differences, which the calculation and reporting 
of effect sizes can remedy.  
Statistical analysis. Within observational research, the use of certain statistical tests, 
such as logistic regression providing odds ratios reporting magnitude and direction of 
differences, help to illustrate practical or clinical significance of observed differences.  Five 
studies utilised such tests, reporting different measures of effect size: two providing 
correlations (Shtayermman, 2007; 2008), one providing ORs (Horowitz et al., 2017), one 
providing Cohen’s d and explained variance (Mayes et al., 2013), the last providing HRs 
(Chen et al., 2017). Additionally, confidence intervals were provided by two of the 
aforementioned studies (Chen et al., 2017; Horowitz et al., 2017), allowing further 
assessment of the precision of the results. 
Running head: SUICIDALITY RISK FACTORS ADOLESCENTS WITH ASD 
36 
 
Participant Characteristics. Given that none of these studies were carried out in the 
UK, generalising findings to a UK population should be done cautiously as there may be 
significant cultural differences, such as the impact of a different socioeconomic climate, or 
population ethnicity composition.  Similarly, these studies being carried out in several 
different countries results in culturally heterogeneous samples, meaning that generalisation of 
findings amongst these studies should be done tentatively as they may also be vulnerable to 
the same potential sociodemographic differences, and thus potential confounding variables, 
highlighted above. 
Unequal Sample Sizes. Whilst a strength of three papers was that they helped control 
for confounding variables by including control subjects (Chen et al., 2017; Mayes et al., 
2013; Mikami et al., 2009), none of these studies reported balanced group sizes; the 
drawback of this being it can affect the power of statistical analysis testing for group 
difference, increasing risk of both “false-positives” and “false-negatives”, depending on how 
the groups are weighted. Mikami et al. (2009) reported a PDD group four times smaller than 
the comparison group, whilst the ASD cohort reported by Mayes et al. (2013) was almost 
four times that of the two comparison groups combined; therefore, caution should be taken in 
inferring definitive conclusions. However, despite reporting an ASD cohort four times 
smaller than the non-ASD controls, the use of matched-controls by Chen et al. (2017) should 
have controlled for unequal group sizes. 
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Recruitment. Several studies note that the nature of recruitment sources and applied 
inclusion criteria increased the risk of selection bias, which could impact on the 
generalisability of findings as the samples may not been representative of the wider 
population of youth with ASD.  Seven studies used clinical samples (Chen et al., 2017; 
Horowitz et al., 2017; Karakoc Demirkaya et al., 2016; Mayes et al., 2013; Mikami et al., 
2009; Mukaddes & Fateh, 2010; Storch et al., 2013); therefore, it is unclear whether risk 
factors identified for these samples correlate to those present in non-clinical samples.  
Data Sources and Collection. Whilst it could be argued that a strength shared 
amongst the studies is that they all clearly describe their data sources, there are limitations in 
the description of the data collection process which hinder drawing substantive conclusions 
from the findings.  Firstly, two studies gathered data on both suicidality and psychological 
disorder diagnosis via review of clinical records (Chen et al., 2017; Mikami et al., 2009). 
Whilst this can be beneficial in terms of amount of data available, clinical records tend to be 
more subject to opinion and therefore at higher risk of reporting bias.  Furthermore, none of 
these studies makes any mention of who was involved in the data collection process; 
therefore, it is not clear how, if at all, reliability and consistency in data interpretation were 
assessed, meaning bias cannot confidently be ruled out in the interpretation of the data in 
these studies. 
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Assessing Suicidality and Psychological Disorder. Seven studies utilised 
standardised measures to assess for suicidality and psychological disorder (Horowitz et al., 
2017; Karakoc Demirkaya et al., 2016; Mayes et al., 2013; Mukaddes & Fateh, 2010; 
Shtayermman, 2007; Shtayermman, 2008; Storch et al., 2013), helping in both ensuring 
consistency in the identification and measurement of variables, and in the generalisability of 
findings; however, the exact measures included vary between the studies, meaning that 
consistency cannot be assumed between the studies, hampering any generalisability of 
findings.  
Another issue concerns suitability of the measures administered.  Karakoc Demirkaya et al. 
(2016) reported that the measures employed in their study were originally designed for 
typically-developing populations.  None of the other studies collecting data from young 
people, and not solely parental report, appeared to have employed measures designed for 
ASD populations, so whilst they may have been shown to be valid and reliable with non-ASD 
samples, they may not be appropriately sensitive in assessing for psychological disorders 
with this population. 
Lastly, studies varied regarding who made reports of suicidality.  Of the eight studies 
employing measures or clinical interview, three studies used young person report of 
suicidality only, with the remaining five using either a combination of child- and parent-
report or parent-report only.  This brings into question reliability of report of suicidality in 
these five studies, because, as Horowitz et al. (2017) remarked, it is unclear “which reporter, 
or potentially a combination of the two, will prove to be most meaningful and predictive”, 
increasing the risk of either under-reporting or over-reporting, as it has been suggested that 
suicidal phenomena amongst people with ASD can often be overlooked (Fitzgerald, 2007), 
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potentially due to the high prevalence of non-suicidal self-injury precluding recognition 
(Hannon & Taylor, 2013).  
ASD Diagnosis. The heterogeneity of ASD diagnosis characterising samples limits 
the generalisability of findings across the wider ASD population; given the differences 
between diagnostic presentations, it is not possible to conclude from these studies whether 
certain risk factors are specific to certain ASD diagnoses, or whether they are relevant across 
the diagnostic spectrum. 
Assessing ASD. A crucial component of ASD research is the confirmation that all 
participants actually meet criteria for a diagnosis, a task made robust through the use of 
recognised reliable and validated assessment tools.  Within this review, only two studies 
employed the “gold standard” ASD diagnostic assessment tool (Horowitz et al., 2017; Storch 
et al., 2013); of the remaining seven, four used different measures of ASD (Mayes et al., 
2013; Mikami et al., 2009; Shtayermman, 2007; 2008), the rest relying on clinical judgement 
based on DSM criteria (Chen et al., 2017; Karakoc Demirkaya et al., 2016; Mukaddes & 
Fateh, 2010). 
Therefore, inconsistency in diagnostic assessment tools employed between studies adds to the 
difficulty in generalising findings resulting from heterogeneity of ASD presentations, as there 
has been limited scope to control for severity of ASD presentation, and consequently the 
relationship between presentation and suicidality.  Of the studies, only Shtayermann (2007; 
2008) included severity of presentation within their studies. 
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Difference in Study Focus and Risk Factors of Interest. Given that the aspect of 
suicidality investigated differed between studies, it is therefore difficult to generalise the role 
of risk factors across all types of suicidality; for example, it could be that a significant factor 
associated with suicidal ideation has no significant association with suicidal behaviour.  
Furthermore, despite much overlay across studies, no study matches another exactly in terms 
of factors investigated.  For example, not only did the range of psychological disorders 
investigated vary, they also differed in how they were included in the analysis: whilst some 
studies investigated depression, anxiety and ADHD as individual factors, others investigated 
them as members of collections of psychological disorders, mood disorders, anxiety disorders 
and disruptive behaviour disorders, respectively.  In some cases, factors for which significant 
associations were observed were included in one particular study e.g. psychotic features and 
family history (Karakoc Demirkaya et al., 2016).  Investigation of socio-demographic factors 
was also limited, with only two studies including factors above gender and age. 
The lack of consistency in variables of interest between studies means that the level of 
control of potential confounding variables varied between studies, and therefore it is not 
possible to rule out the role of variables of interest from one study being unaccounted for as 
confounding variables in another.  Consequently, due to the potential impact of unaccounted 
confounding variables, one should be cautious in generalising these findings. 
Discussion 
Summary of findings of the Review 
This review appraised the research investigating suicidality in children and adolescents with 
ASD, guided by the following research questions:  
1. How prevalent is suicidality amongst children and adolescents with ASD? 
Running head: SUICIDALITY RISK FACTORS ADOLESCENTS WITH ASD 
41 
 
2. What does the research tell us about the risk factors associated with suicidality in this 
population? 
In total, nine papers were identified and included in this review.  In terms of prevalence of 
suicidality within ASD specifically, presence of any suicidal phenomenon ranged from 3.9% 
to 50%, broken down between suicidal ideation (10.9% to 50%), and suicidal 
behaviour/attempt (3.9% and 12.7%): these rates are comparable to those identified in the 
population-based adolescent studies, with rates of suicidal ideation and attempt within this 
population reported to be 20-30% and 10%, respectively (Evans et al., 2005). These findings 
indicate that risk of suicidality in individuals with ASD is not isolated to adults, and that 
young people with ASD are at a similar level of risk of suicidality as their typically-
developed counterparts.  
With regards to associated risk factors, the research suggests a range of psychological and 
sociodemographic factors may be associated with increased risk of suicidality in youth with 
ASD; however, due to inconsistency between studies in factors investigated and assessment 
measures, generalisability of findings is dubious and therefore any conclusions drawn should 
be tentative.  Additionally, given only Chen et al. (2017) investigated any temporal 
relationship between suicidality and risk factors, it is not possible to reliably infer conclusions 
about causal relationships between suicidality and any of the associated factors identified. 
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Factors Associated with Suicidality in ASD 
ASD Presentation. The research suggests that suicidality may vary between different 
diagnoses along the autistic spectrum.  children with Autism were found more likely to report 
suicidality than those with Asperger’s (Storch et al, 2013); however, this was only reported in 
a single study and therefore is difficult to generalise. 
Psychological Disorders. In terms of psychological disorders, significant associations 
were identified with:  
• Depression 
• PTSD 
• Substance-use disorder 
• Alcohol-use disorder 
• Mood disorders 
• Anxiety disorders 
• Psychotic features 
• Behavioural problems 
Of these, depression was the most widely identified risk factor, and was shown to have a 
temporal relationship with subsequent suicide attempts in adolescents, as did substance-use 
disorder (Chen et al., 2017).  
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Socio-demographic factors. Several socio-demographic factors were identified as 
potential risk factors: gender, low SES and ethnicity (Mayes et al., 2013); age (Mayes et al., 
2013; Mukaddes & Fateh, 2010); family history of lethal and nonlethal suicidal behaviours 
and family history of completed suicide (Karakoc Demirkaya et al., 2016). It was also 
suggested that relationship conflict, such as bullying or teasing, may also be associated with 
suicidality (Mayes et al., 2013; Mikami et al., 2009).  
Only one study carried out analysis to test for a causal or temporal relationship; furthermore, 
none of the studies in this review ran a comparison against non-ASD controls to test whether 
any of the aforementioned factors were specific to ASD, or whether ASD might act as a 
moderating factor, with the relationships between factors and suicidality being more or less 
significant within ASD populations.  Consequently, it is not currently possible to confidently 
infer conclusions about these associations, highlighting the need for further research in this 
area. 
Limitations of the Review 
This review focused solely on quantitative studies into suicidality in children and adolescents 
with ASD, excluding both qualitative studies and case studies.  It is possible that these 
particular methodologies, given their ability to focus more on an individual and their 
experience, may be helpful and more adept at identifying mechanisms and processes 
associated with particular risk factors.  Therefore, omitting these studies may have limited the 
extent of possible conclusions able to be inferred in this review.  
Clinical Implications 
As none of these studies were conducted with UK samples, generalisability and implications 
of these findings for clinical practice in the UK are tentative.  However, there are several 
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potential avenues arising from these findings for development of clinical practice.  Firstly, 
whilst inferring definitive conclusions should be done cautiously, these findings could help 
inform the development of service protocols geared towards minimising either risk of, or 
preventing escalation of, suicidality in adolescents with ASD.  Those identified to be at 
higher risk of suicidality may benefit from more frequent risk assessment in order to reduce 
the likelihood that suicidality goes unnoticed and therefore potentially escalates to 
engagement in life-threatening behaviours.  This type of early identification could help 
ensure that those requiring intervention do not get overlooked and receive appropriate support 
in a timely manner.  Secondly, better understanding of associated risk factors could help 
inform the development of preventative interventions tailored to address specific factors, such 
as difficulties related to psychological disorders, social communication difficulties, or 
difficulties within peer relationships. 
Research Implications 
The findings of this review identify multiple potential risk factors for suicidality in youth 
with ASD.  Further research is required to hone understanding of these risk factors, and the 
related mechanisms at play.  Firstly, given no study investigated UK samples, UK-based 
research would help to ascertain whether these findings are generalisable to UK samples, or 
whether there are significant sociodemographic differences with the countries of origin which 
would dismiss any relevance.  Given the majority of studies used cross-sectional analysis, 
with only one study employing a longitudinal approach, future research should use 
longitudinal analysis to assess for any causal relationships with suicidality. 
Despite considerable overlap, factors, both psychological and sociodemographic, investigated 
varied greatly between studies, making it difficult to rule out influence of potential 
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confounding variables.  Future studies should consolidate all factors investigated across these 
studies to help better control for confounding variables.  Specifically, studies should aim to 
investigate individual psychological diagnoses, rather than collections, and also include a 
comprehensive range of socio-demographic factors:  
• Ethnicity 
• SES 
• sexual orientation 
• relational factors (e.g. peer victimisation) 
• trauma history 
• family history of suicidality 
• family mental health history 
• educational history 
• family composition (e.g. number of siblings, age positioning within family) 
• Treatment factors to be investigated: 
o Psychological intervention 
o Psychopharmacological intervention 
Including these factors would help investigate cultural factors related specifically to the UK 
and control for potential cultural differences, enhancing generalisability of findings.  
Running head: SUICIDALITY RISK FACTORS ADOLESCENTS WITH ASD 
46 
 
Additionally, alongside risk factors, identifying protective factors should be included as a 
future research aim.  
Suicidal phenomenon investigated differed between studies, making it difficult to generalise 
the role of risk factors across all phenomenon.  Future studies should investigate different 
aspects of suicidality as separate outcome variables when attempting to identify relevant risk 
factors. 
Only one study investigated the relationship between different aspects of suicidality, 
reporting suicidal ideation to be the strongest single risk factor for suicide attempt.  
Therefore, further research is needed to assess the relationship between existing/historical 
suicidality and later incidences, as this could shed light on the progression trajectory for 
suicidality.  
Without comparison groups, it is difficult to make conclusions about any uniqueness of 
relationship between these factors and suicidality in ASD.  Lack of control subjects within all 
but one study makes it impossible to conclude whether these factors are specific to ASD, or 
whether the strength of association is significantly different from non-ASD samples.  
Furthermore, findings were mixed when comparing different ASD diagnoses, and no study 
investigated whether significance of associations differed between clinical and community 
samples.  Future studies should include non-ASD controls, differential diagnoses, and both 
clinical and community samples.  It could also be beneficial when comparing different ASD 
diagnosis samples to stratify samples in terms of age, given its potential association. 
Once risk factors have been robustly investigated and causal relationships have been 
indicated, studies should investigate identified at-risk groups (e.g. depression) to develop 
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understanding of the risk mechanisms and processes explaining the relationship between risk 
factors and suicidality. 
To reduce risk of reporting bias associated with subjective measures (e.g. clinical notes), 
studies should prioritise using objective and standardised measures, where possible, to 
investigate factors of interest. 
No psychometric measure reported in this review was designed for use with an ASD 
population, bringing into question the reliability, sensitivity, and validity of using these 
measures with this population. Therefore, future studies should aim to use measures designed 
for use with ASD samples; should these be unavailable, development of such measures 
should be a priority to improve report and identification of psychological distress within this 
population. For example, individuals with ASD have the propensity to make literal 
interpretations of more figurative uses of language for literal understanding of language (Frith 
& Happe, 2005): updating the language used in measures to accommodate this tendency 
could reduce the possibility of misunderstanding or misinterpretation of questions when 
administrating a measure, increasing the validity of the measure for use within an ASD 
population. However, in creating bespoke measures, there is a risk of emphasising differences 
associated with individuals with ASD, relative to the typically-developed population, and 
creating a sense of ‘othering’ within those diagnoses with ASD. Additionally, in creating and 
using of ASD-specific measures, there is the risk that characteristics shared between those 
with ASD and typically-developing individuals will be overlooked by such measures. 
Therefore, these issues should be considered when pursuing development of such measures. 
Given the heterogeneity of presentation associated with respective psychological disorder 
labels, investigating specific characteristics associated with individual diagnoses would help 
Running head: SUICIDALITY RISK FACTORS ADOLESCENTS WITH ASD 
48 
 
to improve understanding of the nature of the relationship between psychological factors and 
suicidality, potentially identifying mechanisms responsible for said relationships.  This would 
be particularly relevant to ASD populations, as there can be additional characteristics present 
within children and adolescents with ASD, compared to non-ASD populations (Ghaziuddin, 
2005; Magnuson & Constantino, 2011).  
No study included psychological theory as part of their examination of suicidality within 
adolescents with ASD. Lack of attention to the investigation of theoretical models limits the 
available research to infer conclusions around the causal mechanisms at play between risk 
factors and suicidality; therefore, future research should endeavour to include psychological 
theory as part of studies to improve understanding of causal mechanisms behind suicidality 
within this population. 
Moreover, further study should investigate the relationship between identified risk factors and 
variations in suicidal phenomenology; for example, whether is there a relationship between 
type of suicide methodology chosen and specific psychiatric diagnosis, or whether certain 
diagnoses are associated with higher frequency or greater severity of suicidality.  
Conclusion 
This review aimed to explore the current state of research on suicidality in children and 
adolescents with diagnoses of ASD, examining prevalence and associated risk factors.  From 
the nine papers identified, suicidality has consistently been shown to be a significant health 
issue in young people with ASD; however, findings regarding risk factors have been 
somewhat mixed and difficult to generalise across the wider youth ASD population, due to 
several methodological variations and issues (e.g. inconsistency in suicidal phenomena 
investigated, heterogeneity in diagnosis of ASD between studies).  However, the review 
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suggests that there are a variety of psychological and socio-demographic risk factors 
associated with suicidality in children and adolescents with ASD.  
Future studies should use UK samples to investigate the relationship between suicidality and 
youth with ASD including all factors investigated across these studies.  Additionally, studies 
should look to investigate specific risk factors (e.g. depression) to identify the risk 
mechanisms pertaining to suicidality (e.g. specific profile of low mood with irritability).  
Better understanding of risk factors could help identify at-risk individuals potentially 
requiring increased risk assessment and support, and in doing so hopefully both minimising 
likelihood of suicidality going unnoticed and improving possibility of timely intervention. 
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Abstract 
Background: Suicidality, suicidal ideation and suicidal behaviour, is a significant health 
concern for adolescents with Autism Spectrum Disorders (ASD).  Depression and Irritability 
have been identified as risk factors for suicidality in autistic adolescents.  Autistic youth may 
have higher vulnerability to these factors than typically-developing adolescents.  No study 
has compared the relationship between suicidality and different depressive profiles, nor used 
a UK clinical sample.  This study investigated depression, irritability, and specific depressive 
profiles as risk factors for suicidality in adolescents with ASD within a UK clinical 
population.  Method: This clinical cohort study used archival data extracted from an 
electronic mental health records database.  The sample consisted of 1314 adolescents (13+ 
years) who received an ICD-10 ASD diagnosis between 2008 and 2013.  Outcome measure 
was suicidality, with exposure variables of depression, irritability, and specific profiles 
(depression with co-occurring irritability (DWI), depression without co-occurring irritability 
(DNI), and irritability without co-occurring depression (IND)).  Results: Cross-sectional 
analysis found depression to be associated with higher likelihood of suicidality.  Irritability 
was found to be associated with higher likelihood of suicidality, even after controlling for 
depression.  DWI was a more significant predictor of suicidality than IND, but no different 
from DNI.  Psychosis, being female, antidepressant use, and caregiver mental health 
difficulties were also positively associated with suicidality, but significantly less likely in 
individuals diagnosed with ID.  Conclusions: Results indicate multiple characteristics of 
adolescents with ASD at high-risk of suicidality.  Early identification of high-risk individuals 
could help deliver timely intervention, potentially reducing both incidence and progression of 
suicidality.   
Keywords: Suicidality, Adolescent, Depression, Irritability 
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Introduction 
Autism Spectrum Disorders (ASD) 
ASD is defined as a neurodevelopmental disorder, typically categorised by deficits in social 
communication, social interaction and sensory processing, with co-occurring repetitive 
stereotyped behaviours, rigid thinking style and highly specific interests, present from early 
on in a person’s development (APA, American Psychiatric Association, 2013). The 
Diagnostic and Statistical Manual 5th edition (DSM-V; APA, 2013), employs ASD as the 
collective term encompassing several previous specific diagnoses: autism/autistic disorder, 
Asperger’s syndrome, and pervasive developmental disorder-not otherwise specified. 
In the UK, it is thought that ASD occurs in approximately 1% of the child population (Baron-
Cohen et al., 2009); however, Baron -Cohen et al (2009) found a ratio of 2:3 when comparing 
known cases to undiagnosed cases, suggesting that rates may actually be higher than 
originally thought.  
Research suggests a propensity towards a diagnosis of ASD amongst males, with a male to 
female ratio of 4:1 commonly cited (Halladay et al., 2015).  However, a recent systematic 
review by Loomes, Hull, and Mandy (2017), suggested that the gender ratio is actually closer 
to 3:1. Furthermore, it has been suggested that presentation of ASD traits may differ between 
genders (Werling & Geschwind, 2013), differing in core ASD features: males with ASD are 
more likely to display externalising behavioural difficulties (e.g. hyperactivity, aggression), 
whereas females with ASD are more likely to present with internalising difficulties (e.g. 
depression, anxiety) (Mandy et al., 2012). 
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Suicidality in Adolescents with ASD 
Suicidality is globally recognised as a major public health issue.  The National Strategy for 
Suicide Prevention (Center for Mental Health Services (US) & Office of the Surgeon General 
(US), 2001) defines “suicidality” as the collective term for a range of suicidal phenomena: 
• Suicidal ideation: thoughts pertaining to suicide/suicidal behaviour. 
• Suicidal plans: thoughts around method of carrying out suicidal behaviour. 
• Suicidal attempt: an unsuccessful attempt to engage in behaviour with intended 
outcome to die as a result of the act. 
• Completed suicide: death occurring as a result of direct behaviour intended to end 
one’s life. 
Suicide is one of the leading causes of death in young adults in the UK (Office of National 
Statistics, 2016), and the second leading cause of death globally amongst 10- to 24-year olds 
(Hawton et al., 2012).  With regards to those with ASD, a recent study found suicide to be a 
leading cause of premature death amongst this population (Hirvikoski et al., 2016).  
Suicidality has been identified as a significant public health issue amongst typically-
developing adolescents (Evans et al., 2005).  Similarly, in a review on suicidality in youth 
with ASD, Kikoler (in preparation) found suicidality to pose significant risk to adolescents 
with ASD, citing prevalence of any suicidal phenomenon ranging from 3.9% to 50%, broken 
down between suicidal ideation (10.9% to 50%), and suicidal behaviour/attempt (3.9% and 
12.7%), rates comparable to those identified in population-based typically-developed 
adolescent studies, indicating that young people with ASD are at a similar level of risk of 
suicidality as their typically-developed counterparts. Adolescence has also been identified as 
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a period of increase for suicidality in individuals with ASD.  For example, Mayes, Gorman, 
Hillwig-Garcia, and Syed (2013) found being older than 10 years to be a risk factor for 
suicidality in autistic youth older than 10 years, whilst Mukaddes and Fateh (2010) reported 
that all of their patients with AS who disclosed suicidal phenomena were adolescents. 
Interpersonal-Psychological Theory of Suicide 
Whilst a range of theoretical models have been proposed to understand the causal 
mechanisms behind suicidality (Stress-diathesis Model, van Heeringen, 2012; Cognitive 
Model, Wenzel & Beck, 2008), thus far the application of such models to the ASD population 
has been limited; to the author’s knowledge, the only model to have been tested with this 
population is the Interpersonal-Psychological Theory of Suicide (IPTS: Joiner, 2007; Van 
Orden et al., 2010). 
The IPTS model proposes an individual will engage in suicidal behaviours if the following 
two conditions are met: firstly, they have the desire to die, also referred to as suicidal 
ideation; secondly, they have the capability to carry out acts driven by said desire.  
Furthermore, these conditions arise out of the interplay between three factors (see Figure 1):  
1. Thwarted belongingness: characterised by self-reported feelings of loneliness 
or alienation, absence of reciprocal social relationship, limited social support, 
and social relationship breakdown. 
2. Perceived burdensomeness: characterised by “the perception that one has 
become a hopeless burden on family and friends” (Pelton & Cassidy, 2017), 
and can be associated with unemployment, long-term physical illness, and low 
self-esteem. 
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3. Acquired Capability for Suicide. 
According to IPTS, it is the combination of Thwarted Belongingness and Perceived 
Burdensomeness that leads to suicidal ideation and the desire to die, developing from 
acquired feelings of hopelessness and belief that if they were dead their friends and/or family 
would be better off.  Furthermore, it is the introduction of Acquired Capability for Suicide 
that leads to a person progressing from suicidal ideation to suicide attempt; IPTS posits this is 
acquired through someone overcoming their innate drive for self-preservation, resulting in 
reduced fear of death and increased pain tolerance (see Figure 2). 
IPTS also claims suicidality presentation varies significantly between different psychological 
disorders due to the heterogeneity in difficulties.  For example, depression is associated with 
increased likelihood of behaviours associated with both Thwarted Belongingness (e.g. due to 
increases in social withdrawal), and Perceived Burdensomeness (e.g. due to increases in low 
self-esteem), and therefore a higher risk of suicidal ideation; whereas Post-Traumatic Stress 
Disorder is associated with Acquired Capability for Suicide only; currently no single 
diagnosis has been found to be associated with all three factors in the model (Silva, Ribeiro, 
& Joiner, 2015).
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Figure 1.  The interpersonal psychological theory of suicide and hypothesized interaction 
with autistic traits (adapted from Pelton & Cassidy, 2017). 
 
Figure 2.  The interpersonal psychological theory of suicide (adapted from Stewart, Eaddy, 
Horton, Hughes, & Kennard, 2017). 
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IPTS has been shown to have validity in explaining the causal mechanisms associated with 
suicidality in both adults (Van Orden, Witte, Gordon, Bender, & Joiner Jr, 2008), and 
adolescents (S. M. Stewart et al., 2017).  To date, only one study has tested IPTS in the 
context of ASD.  Pelton and Cassidy (2017) investigated the association between autistic 
traits and suicidality within a sample of young adults, finding a significant relationship 
between autistic traits and suicidality, mediated by both Thwarted Belongingness and 
Perceived Burdensomeness, and that autistic traits significantly predicted both Thwarted 
Belongingness and Perceived Burdensomeness, indicating validity of using IPTS with 
individuals with autistic traits. They postulated that behaviours suggestive of the presence of 
both Thwarted Belongingness (e.g. self-reported feelings of loneliness, limited social 
support), and Perceived Burdensomeness (e.g. unemployment, family burden), were also 
related to high levels of autistic traits, and therefore individuals with high autistic traits were 
at risk of suicidality due to increased likelihood of experiencing Thwarted Belongingness and 
Perceived Burdensomeness. Pelton and Cassidy (2017) also found depression to significantly 
predict both Thwarted Belongingness and Perceived Burdensomeness within their sample. 
They posited that depression may also be intensified by autistic traits, with the propensity for 
rigid thinking-styles, difficulty switching attentional focus, and repetitive behaviours 
increasing the possibility of engaging in ruminative thinking. Given that depression is 
associated with Thwarted Belongingness and Perceived Burdensomeness, and not Acquired 
Capability for Suicide, Pelton and Cassidy (2017) suggest that, in the presence of autistic 
traits, the association between suicidal ideation (i.e. Thwarted Belongingness and Perceived 
Burdensomeness) and suicidal behaviour (i.e. Acquired Capability for Suicide) is weakened. 
Depression & Suicidality 
Depression has been consistently identified as a risk factor for suicidality amongst typically-
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developing adolescents (Fergusson et al., 2000; Kirkcaldy, Siefen, Urkin, & Merrick, 2006; 
Pelkonen & Marttunen, 2003; Strandheim et al., 2014).  Similarly for adolescents with ASD, 
depression has been identified as a significant risk factor for suicidality (Mayes et al., 2013; 
Storch et al., 2013), and has even been found to have a temporal relationship with suicidality, 
increasing the likelihood of later suicide attempt (Chen et al., 2017).  
Depression is typically characterised by low mood and anhedonia, amongst a combination of 
other difficulties (e.g. sleep disturbances, reduced appetite, fatigue), causing significant 
impairment to daily functioning (APA, 2013). Adolescence has been highlighted as a period 
of increased vulnerability to developing depression, when depressive symptoms significantly 
increase and first depressive episodes develop (Kim-Cohen et al., 2003), visible in the 
comparison of 12-month prevalence of depression in childhood with that in adolescence: 
childhood estimates range from 0.5% to 3% (Birmaher et al., 1996), but increased in 
adolescence to a range of 2% to 8% (Costello, Erkanli, & Angold, 2006).  The increased 
emergence of depression in adolescence is thought to be due to the intense period of 
development, characterised by physical, social, cognitive and neural changes, associated with 
adolescence, changes which are considered likely to play an important role in the 
development of depression.  Features include rapidly developing emotional and motivational 
systems, as well as increasing self-awareness and self-reflection, resulting in a mismatch 
between the need for increases in emotional regulation occurring at a rate faster than the 
responsible cognitive function can develop, not to mention significant changes in social 
environment.  These characteristics have led to adolescence being akin to “starting the engine 
with an unskilled driver” (Dahl, 2004, p.17).  
Like their typically-developing counterparts, there is significant, if not higher, risk of 
depression for adolescents with ASD: several studies have reported higher risk of depression 
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amongst youth with ASD than typically-developing controls (Ghaziuddin, Ghaziuddin, & 
Greden, 2002; Gurney, McPheeters, & Davis, 2006; Stewart, Barnard, Pearson, Hasan, & 
O’Brien, 2006). The increased risk may be due to the impact of the changes associated with 
adolescence potentially exacerbated by core characteristics associated with ASD (Magnuson 
& Constantino, 2011).  For example, changes in social environment and peer relationships 
may increase an autistic individual’s awareness of their diagnosis and the way it makes them 
different from their typically-developing peers and has been associated with greater severity 
of depressive symptoms (Butzer & Konstantareas, 2003).  Given this potential increased risk 
for developing depression, adolescents with ASD may therefore be at higher risk of 
suicidality as they might be more predisposed to developing this particular known risk factor. 
However, ‘Depression’ is a “phenomenologically heterogeneous” label and encompasses a 
range of presentations (Leventhal, Pettit, & Lewinsohn, 2008), which has prompted the 
proposal of distinct depressive presentations to aid diagnosis and help inform treatment 
(Rush, 2007). With regards to ASD, as well as these proposed presentations, it has been 
posited that depression in ASD can present with special features, such as increased 
withdrawal and irritability (p.131; Ghaziuddin, 2005); similarly, Magnuson and Constantino 
(2011) found that depression in ASD-affected children can often be characterised by an 
“atypical presentation”, as well as potentially presenting with additional features, such as 
catatonia and mood lability. Depressive presentations have even been found to vary 
significantly between different ASD diagnoses (Pearson et al., 2006). 
To date, research into the relationship between depression and suicidality has tended to focus 
solely on diagnosis and not investigated difference in relationship between suicidality and 
distinct depressive profiles; therefore, it remains unclear whether specific depressive 
presentations are more associated than others with suicidality, and what aspects of such 
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presentations are responsible for the increase in risk.  Furthermore, given the further 
heterogeneity associated with adolescent depression in ASD, it is also unclear whether a 
depressive profile associated with suicidality within typically-developing adolescents would 
have a similar relationship with ASD, or whether the relevant risk factor is unique to ASD. 
Irritability & Suicidality 
Whilst psychological risk factors have been ubiquitously investigated, several behavioural 
characteristics, such as irritability, have also been identified as having a significant 
association with suicidality.  Irritability is characterised by the DSM-V as "easily annoyed 
and provoked to anger" (APA, 2013), and associated with poor emotional self-regulation. 
From a theoretical standpoint, IPTS proposes an association between emotional-regulation 
difficulties and suicidality: Silva et al. (2015) reported anger to be associated with both 
Thwarted Belongingness and Perceived Burdensomeness, increasing likelihood of suicidal 
ideation. Hawkins et al. (2013), found Perceived Burdensomeness mediated the relationship 
between anger and both suicidal ideation and past suicide attempts, positing that feelings of 
burdensomeness unto others may occur due to anger leading to negative emotional states 
(Tafrate, Kassinove, Dundin, as cited in Hawkins et al., 2013). Irritability has been found to 
be associated with increased probability of suicide attempt in typically-developing 
adolescents (Dour, Cha, & Nock, 2011).  Research also suggests that the association between 
irritability and suicidality carries over into autistic youth: Mayes et al. (2013) found mood 
dysregulation to significantly predict suicidality within their sample of children and 
adolescents with ASD, identified as one of the strongest predictors of suicide attempt, second 
only to suicidal ideation. Whilst not explicitly a diagnostic criterion, irritability is becoming 
increasingly identified as a characteristic endemic to those with ASD (Jahromi, Meek, & 
Ober‐Reynolds, 2012; Samson, Wells, Phillips, Hardan, & Gross, 2015), proposed to be 
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related to innate deficits in both temperament control and ability to be soothed (Samyn, 
Roeyers, & Bijttebier, 2011). As mentioned previously, Perceived Burdensomeness is 
associated with high levels of autistic traits (Pelton & Cassidy, 2017), and given the potential 
predisposition towards irritability, individuals with ASD may be at greater risk of suicidality 
than their typically-developing counterparts when it comes to the influence of this particular 
factor. 
Depression & Irritability 
Whilst observed to be present in a range of psychological disorders in children and 
adolescents (McLaughlin, Hatzenbuehler, Mennin, & Nolen-Hoeksema, 2011), irritability has 
been identified to be particularly related to depression in youth to the extent that irritability 
can be substituted in place of low mood in the diagnosis of depression in children and 
adolescents (APA, 2013; Rao & Chen, 2009).  Irritability has been identified as a 
characteristic highly likely to be observed in depressed youth with ASD (Magnuson & 
Constantino, 2011).  Furthermore, depressive presentations with co-occurring irritability have 
been found to be associated with suicidality in autistic youth, with Mayes et al. (2013) 
reporting that irritability presenting alongside other depressive characteristics, such as 
anhedonia, was associated with increased likelihood of suicidality.  
As highlighted earlier, depression is a diagnostic term representing a range of heterogeneous 
presentations, and to date, research into the relationship between depression and suicidality 
has tended to focus solely on depression as a collective label and not distinct profiles.  It is 
therefore not clear what causal mechanisms are responsible for the relationship between 
depression and suicidality.  Given the identification of irritability as a characteristic endemic 
to ASD, as well as the findings of Mayes et al. (2013), it may be that depression with co-
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occurring irritability is a depressive profile associated with a higher likelihood for suicidality 
in youth with ASD, perhaps more so than other depressive profiles, and therefore might be a 
better and more helpful indicator of those at higher risk of suicidality than looking at 
depression as a collective construct.  
Rationale & Aims 
Adolescence has been identified as a period of increased risk of suicidality in individuals with 
ASD.  This is the first study to look at risk factors in a UK adolescent clinical sample.  
Additionally, to date, no study has looked at the relationship between specific depressive 
profiles and suicidality in adolescents with ASD.  The aim of the study was to identify risk 
factors for suicidality in a clinical sample of adolescents with ASD, specifically exploring the 
roles of depression and irritability as potential risk factors.  Furthermore, this study compared 
the relationship between suicidality and individual depressive and irritability profiles.  Based 
on current knowledge, the following hypotheses were made: 
Hypothesis 1.  Depression will be identified as a significant risk factor for suicidality in 
adolescents with ASD. 
Hypothesis 2.  Irritability will be identified as a significant risk factor for suicidality in 
adolescents with ASD. 
Hypothesis 3.  Part of the relationship, if not all, between irritability and suicidality will be 
explained by depression. 
Hypothesis 4.  Depression with co-occurring irritability will be a stronger predictor for 
suicidality in adolescents with ASD than both depression without co-occurring irritability and 
irritability without co-occurring depression. 
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Method 
Design 
This study was a clinical cohort study, using retrospective collection of data from electronic 
health records. 
Sample 
Participants were selected from an open clinical cohort (entering and exiting the study at 
different times) of children and adolescents aged 5-17, referred to South London and 
Maudsley NHS Foundation Trust (SL&M) Child and Adolescent Mental Health services 
(CAMHS), who received, according to criteria outlined in International Statistical 
Classification of Diseases and Related Health Problems – 10th revision (ICD-10, World 
Health Organization, 1992), a diagnosis of ASD (F84.0, F84.1, F84.5, F84.9) between 1st 
January 2008 and 31st December 2013. 
Inclusion Criteria 
In order to be included in the adolescent cohort, an individual had to be at least 13 years of 
age at time of first contact with services.  This age was selected as it has been identified as an 
age of overlap between the end of the early adolescence, characterised by initial biological 
changes, and the start of adolescence, characterised by significant psychosocial change 
(Curtis, 2015); therefore, 13 years old appears to be the minimum age where all 
developmental changes associated with adolescence begin to occur simultaneously.  
Procedure 
All study data were collected from an anonymised record database consisting of electronic 
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mental health records for children and adolescents referred to SL&M CAMHS between 1st 
January 2008 and 31st December 2013, held in the UK National Institute for Health Research 
Biomedical Research Centre for Mental Health (Perera et al., 2016).  The Clinical Record 
Interactive Search (CRIS) system was used to extract the deidentified dataset for analysis in 
this project.  The dataset extracted consisted of clinician-recorded responses on standardised 
proforma structures, as well as unstructured data from “free text” input (e.g. progress notes, 
clinic letters, etc.), the latter achieved using Generalised Architecture for Text Engineering 
(GATE), a natural language processing (NLP) program (Cunningham, 2002). 
Measures 
Outcome Variable: Suicidality 
Suicidality outcome data were extracted from free text fields using an NLP program adapted 
specifically for and found to be accurate in screening for presence of suicidality within 
electronic health records, of which the author was part of the validation process (see Downs 
et al., 2017). The NLP program initially identifies mentions of suicidality in two ways: 
variations in “suicid*” (e.g. suicidal, suicide), as well as associated phrases (e.g. “kill 
myself/herself/himself/themselves”, “want to die”, “take their own life”) and methods of 
suicidality (e.g. “overdose”, “hanging”).  The program then differentiates between negative 
mentions of suicidality (e.g. “denies suicidal ideation”, “not suicidal” “risk of suicide: low”), 
and positive mentions of suicidality (e.g. “reported suicidal thoughts”, “with suicidal intent”, 
“XXX had contemplated suicide”); for full details of the NLP program protocol see Downs et 
al. (2017) 
Exposure Variable: Depression, Irritability & Individual Profiles  
Exposure variable data were extracted from structured fields and free text within CRIS.  
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Exposure to depression was identified by clinician report in structured fields outlining a 
diagnosis of depressive disorder according to ICD-10 criteria (F32.0).  Data on irritability 
were extracted from clinical notes using NLP, the method for which has been published 
previously and shown to be valid with this database (Jackson et al., 2018; Jackson et al., 
2017). Individuals were allocated to the irritability cohort if there had been at least one 
positive mention of irritability, identified by the presence of a variation on “irrit*” (e.g. 
“irritability”, “irritable”) within the free text (e.g. progress notes, clinical letters, etc.). 
Three distinct profile variables were created using the data extracted for depression and 
irritability from the data as exposure variables.  Of these three, two were depressive profiles: 
depression with co-occurring irritability (DWI), and depression with no co-occurring 
irritability (DNI).  In order to be included in the DWI sample, an individual had to have a 
diagnosis of depression as well as a mention of irritability within a 28-day period either side 
of receiving their depression diagnosis; any mentions of irritability outside of that window 
were considered ineligible to be identified as co-occurring with depression.  All remaining 
individuals with depression diagnoses were allocated to the DNI group.  The remaining 
profile, irritability without co-occurring depression (IND), consisted of those with identified 
irritability but never having received a diagnosis of depression. 
Covariates 
A range of clinical and demographic variables was extracted and included in the analysis as 
covariates.  Demographic variables included sex, age at ASD diagnosis, age at first contact 
with CAMHS, age of first suicidal event.  Data on ethnicity (‘White’, ‘Black’ ‘Asian’, 
‘Mixed’, ‘Other/Not stated’; as outlined by UK Office of National Statistics), level of 
neighbourhood deprivation based on UK census data, divided into three tiers (‘Least 
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deprived’, ‘Moderately deprived’, ‘Most deprived’), and caregiver mental health status were 
also extracted.  Clinical data were collected regarding both co-occurring psychiatric disorders 
based on ICD-10 diagnostic criteria, and co-occurring neurodevelopmental disorders of 
attention deficit hyperactivity disorder (ADHD; ICD-10, F90), and intellectual disability (ID; 
ICD-10, F70-79).  Information around prescription of psychotropic medications 
(antidepressants, antipsychotics) was also extracted.  Baseline level of adaptive functioning 
was collected, measured by scores on the Children’s Global Assessment Scale (CGAS, 
Shaffer et al., 1983). 
Ethical Approval 
Ethical approval for this study fell under an existing approval for use of the CRIS database 
for empirical study, granted by the Oxfordshire Ethics Committee, as part of a wider study 
using the CRIS database (ref: 08/H0606/71+5, see Appendix C).  Approval for this project 
specifically was sought and granted by CRIS ethics committee (ref: 15-104, see Appendix 
D).  
Data Analysis 
Statistical analysis was conducted using STATA version 13 (Statacorp, 2013).  Following 
extraction from CRIS, the raw datasets had to be combined and cleaned prior to analysis 
being possible.  Sample characteristics were analysed, with group differences tested using 
chi-square tests of independence for comparison of frequencies, and independent t-tests were 
conducted to test for difference in means.  A series of multivariate binary logistic regression 
analyses were conducted to explore variables as potential risk factors for suicidality, with 
Odds Ratios (OR) calculated as measure of effect size. 
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Results 
An initial sample of 1950 youth with ASD was identified.  After screening for exclusion 
criteria, 636 were removed; the final sample consisted of 1314 adolescents with ASD. 
Sample Characteristics 
Sample characteristics for the total sample was presented in Table 1.  The sample consisted of 
1314 adolescents with an ASD diagnosis, and was predominantly male (78.4%), with the 
gender ratio of approximately 4:1 appearing representative of that in reported in community 
ASD populations.  The mean age at first contact with services was 15.27 (SD=1.43, range 
=13.01-17.94); mean age at ASD diagnosis was 14.98 (SD=1.80, range 6.65-17.95).  
Individuals came from a variety of ethnicities, with ‘White” the most common (56.23%), 
followed by ‘Black’ (19.77%).  The sample was evenly split in terms of level of 
neighbourhood deprivation, and 22.88% of the sample had caregivers with identified mental 
health difficulties.  Several types of psychotropic medication prescriptions were identified, 
the most common of which were antipsychotics (21.23%), followed by antidepressants 
(14.84%).  A range of psychological disorders were identified amongst the sample: 
depression (9.36%); anxiety (2.36%); psychotic disorder (8.37%); conduct disorder 
(10.27%); eating disorder (1.22%); tic disorder (1.52%); obsessive-compulsive disorder 
(5.48%).  Diagnoses of co-occurring neurodevelopmental disorders of Attention Deficit 
Hyperactivity Disorder (ADHD; 20.62%) and Intellectual Disability (ID; 28.46%); 36.53% 
were also reported to have displayed irritability. The mean score on the CGAS, measuring 
level of baseline function, was 46.55 (SD=15.08, range=4-92), scoring within the “obvious 
problems” range. 
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Table 1  
Sociodemographic and Clinical Characteristics of total sample. 
 
  
Sample Characteristic 
Total Sample 
(n=1314) 
Sex 
 Male 686 (78.4) 
 Female 189 (21.6) 
Age at ASD diagnosis, mean (SD) 14.85 (1.90) 
Age of first contact with services, mean (SD) 15.28 (1.43) 
Ethnicity 
 White 492 (56.23) 
 Black 173 (19.77) 
 Asian 40 (4.57) 
 Mixed 78 (8.91) 
 Other or Not stated 92 (10.51) 
Level of neighbourhood deprivation 
 Least deprived 319 (39.33) 
 Moderately deprived 240 (29.59) 
 Most deprived 252 (31.07) 
Caregiver mental health difficulties 253 (22.88) 
Medication 
 Antidepressant 195 (14.84) 
 Antipsychotic 279 (21.23) 
Co-occurring Psychological Disorders 
 Depression 123 (9.36) 
 Anxiety Disorder 31 (2.36) 
 Psychosis 110 (8.37) 
 Conduct Disorder 135 (10.27) 
 Eating Disorder 16 (1.22) 
 Tic Disorder 20 (1.52) 
 OCD 72 (5.48) 
Irritability 480 (36.53) 
Co-occurring Neurodevelopmental Disorders 
 ADHD 271 (20.62) 
 Intellectual Disability 249 (28.46) 
Baseline function 
  CGAS Score, mean (SD) 46.55 (15.08) 
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Suicidality 
Sample characteristics are presented for the non-suicidal and suicidal samples in Table 2.  Of 
the sample, 50.17% reported suicidality at least once during their time in contact with 
services.  In comparison to the non-suicidal sample, the suicidal group had a higher 
proportion of females (χ2 (1) = 40.00, p <.001), and higher mean age at ASD diagnosis (t 
(1312) = -3.79, p <.001).  Sample ethnicity was significantly different, with the suicidal 
sample having higher proportions of individuals from ‘white’ and ‘mixed’ backgrounds (χ2 
(4) = 20.67, p <.001), as well as a higher percentage of youth with caregivers with mental 
health difficulties (χ2 (1) = 19.67, p <.001).  There were significantly higher rates in the 
suicidal sample of both antidepressants (χ2 (1) = 84.43, p <.001), and antipsychotics (χ2 (1) 
=23.35, p <.001).  In terms of psychological disorders, the suicidal sample showed higher 
rates of depression (χ2 (1) = 96.43, p <.001), psychotic disorder (χ2 (1) = 46.38, p <.001), and 
OCD (χ2 (1) = 11.07, p = 0.001); a higher proportion of irritability was also reported for the 
suicidal sample (χ2(1) =108.19, p <.001).  Of the neurodevelopmental disorders identified, 
there was a significantly lower proportion of ID in the suicidal sample (χ2(1) =45.68, p 
<.001); the suicidal sample also showed significant higher score on the CGAS at baseline (t 
(1174) =-1.78, p = 0.08). 
Risk factors for Suicidality 
Unless mentioned otherwise, all associations reported are positive.  
Hypothesis 1: Depression 
Sample Characteristics for the Depression sample are presented in Table 3.  Of the depression 
cohort, 73.17% reported suicidality.  The first analysis assessed the role of depression as a 
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Table 2 
Sociodemographic and Clinical Characteristics of suicidal and non-suicidal cohorts. 
 
Sample Characteristic 
Total Sample (n=1314) 
Test statistic 
value (df) p-value 
Non-Suicidal 
Sample (n=875) 
Suicidal Sample 
(n=439) 
Sex 
 Male 686 (78.4) 272 (61.96) χ
2 (1)=40.00 <.001 
 Female 189 (21.6) 167 (38.04)   
Age at ASD diagnosis, mean 
(SD) 14.85 (1.90) 15.24 (1.55) t (1312) = -3.79 <.001 
Age of first contact with 
services, mean (SD) 15.28 (1.43) 15.25 (1.29) t (916) = - 0.30 0.77 
Age at first report of 
suicidality, mean (SD) N/A 15.45 (1.39)   
Ethnicity 
 White 492 (56.23) 288 (65.6) χ
2 (4)=20.67 <.001 
 Black 173 (19.77) 66 (15.03)   
 Asian 40 (4.57) 20 (4.56)   
 Mixed 78 (8.91) 45 (10.25)   
 Other or Not stated 92 (10.51) 20 (4.56)   
Level of neighbourhood deprivation 
 Least deprived 319 (39.33) 180 (43.06) χ
2 (2)=2.28 0.32 
 Moderately deprived 240 (29.59) 124 (29.67)   
 Most deprived 252 (31.07) 114 (27.27)   
Caregiver mental health 
difficulties 131 (18.63) 122 (30.27) χ2 (1)=19.67 <.001 
Medication 
 Antidepressant 74 (8.46) 121 (27.56) χ
2 (1)=84.43 <.001 
 Antipsychotic 152 (17.37) 127 (28.93) χ
2 (1)=23.35 <.001 
Co-occurring Psychological 
Disorders     
 Depressive Disorder 33 (3.77) 90 (20.5) χ
2 (1)=96.43 <.001 
 Anxiety Disorder 15 (1.71) 16 (3.64) χ
2 (1)=4.73 0.03 
 Psychosis 41 (4.69) 69 (15.72) χ
2 (1)=46.38 <.001 
 Conduct Disorder 82 (9.37) 53 (12.07) χ
2 (1)=2.34 0.13 
 Eating Disorder 9 (1.03) 7 (1.59) χ
2 (1)=0.78 0.38 
 Tic Disorder 12 (1.37) 8 (1.82) χ
2 (1)=.40 0.53 
 OCD 35 (4.00) 37 (8.43) χ
2 (1)=11.07 0.001 
Irritability 234 (26.74) 246 (56.04) χ2 (1)=108.19 <.001 
Co-occurring Neurodevelopmental Disorders 
 ADHD 182 (20.8) 89 (20.27) χ
2 (1)=.05 0.82 
 Intellectual Disability 249 (28.46) 52 (11.85) χ
2 (1)=45.68 <.001 
Baseline function 
 CGAS Score, mean (SD) 45.98 (16.29) 47.61 (12.51) t (1174)=-1.78 0.08 
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Table 3 
Sociodemographic and Clinical Characteristics of depression cohort. 
Sample Characteristic 
Total Sample (n=123) 
Test statistic 
value (df) p-value 
Percentage 
of Total 
Cohort 
Non-Suicidal 
Sample 
(n=33) 
Suicidal 
Sample 
(n=90) 
Sex 
 Male 25 (75.76) 43 (47.78) χ
2 (1)=7.65 0.006 9.91% 
 Female 8 (24.24) 47 (52.22)   29.10% 
Age at ASD diagnosis, 
mean (SD) 15.24 (1.65) 15.59 (1.42) t (121) = -1.14 0.27  
Age of first contact with 
services, mean (SD) 15.29 (1.38) 15.50 (1.29) t (115) = - 0.73 0.47  
Age at first report of 
suicidality, mean (SD) N/A 15.50 (1.36)    
Ethnicity 
 White 22 (66.67) 60 (66.67) χ
2 (4)=6.35 0.17 17.89% 
 Black 4 (12.12) 18 (20)   12.72% 
 Asian 2 (6.06) 5 (5.56)   17.50% 
 Mixed 3 (9.09) 7 (7.78)   12.82% 
 Other or Not stated 2 (6.06) 0 (0)   2.17% 
Level of neighbourhood deprivation 
 Least deprived 13 (43.33) 36 (42.86) χ
2 (2)=2.30 0.89 15.36% 
 Moderately deprived 10 (33.33) 25 (29.76)   14.58% 
 Most deprived 7 (23.33) 23 (27.38)   11.90% 
Caregiver mental health 
difficulties 11 (35.48) 30 (34.09) χ2 (1)=0.02 0.89 16.21% 
Medication 
 Antidepressant 13 (39.39) 53 (58.89) χ
2 (1)=3.69 0.055 33.85% 
 Antipsychotic 14 (42.42) 25 (27.78) χ
2 (1)=2.39 0.12 13.98% 
Co-occurring Psychological Disorders 
 Anxiety Disorder 4 (12.12) 3 (3.33) χ
2 (1)=3.47 0.06 22.58% 
 Conduct Disorder 4 (12.12) 7 (7.78) χ
2 (1)=0.56 0.46 10.00% 
 Psychosis 6 (18.18) 21 (23.33) χ
2 (1)=0.37 0.54 20.00% 
 Eating Disorder 0 (0) 2 (2.22) χ
2 (1)=0.75 0.39 12.50% 
 Tic Disorder 1 (3.03) 0 (0) χ
2 (1)=2.75 0.10 5.00% 
 OCD 4 (12.12) 5 (5.56) χ
2 (1)=1.53 0.22 12.50% 
Irritability 19 (57.58) 65 (72.22) χ2 (1)=2.39 0.12 17.50% 
Co-occurring Neurodevelopmental Disorders 
 ADHD 8 (24.24) 9 (10.00) χ
2 (1)=4.11 0.043 6.27% 
 Intellectual Disability 8 (24.24) 7 (7.78) χ
2 (1)=6.11 0.013 6.02% 
Baseline function 
 
CGAS Score, mean 
(SD) 44.03 (12.63) 
50.34 
(11.01) t (119) =-1.78 0.009  
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risk factor for suicidality in adolescents with ASD.  A multivariate binary logistic regression 
analysis was conducted, undergoing four iterations: Model 1 included depression as a sole 
predictor; Model 2 adjusted for sociodemographic factors; Model 3 further adjusted for both 
psychological and neurodevelopmental disorders; Model 4 was the final iteration, including 
psychotropic medications (see Table 4). 
After adjusting for sociodemographic factors, co-occurring diagnoses and psychotropic 
medication, depression remained significantly associated with suicidality (OR 3.18, 1.94-
5.21).  In terms of sociodemographic factors, there was a significant association identified 
with gender (OR 0.56, 0.41-0.77), with females more likely to report suicidality; additionally, 
having a caregiver with mental health difficulties was also significantly associated with 
suicidality (OR 1.54, 1.10-2.14).  Psychotic disorder was the only other psychological 
disorder found to be associated with suicidality (OR 2.15, 1.25-3.68), whilst ID was found to 
have a negative association (OR 0.33, 0.22-0.49) with individuals significantly less likely to 
be in the suicidal group.  Lastly, individuals were more likely to be in the suicidal sample if 
taking antidepressants (OR 2.08, 1.39-3.11), or antipsychotics (OR 1.56, 1.06-2.30). 
Hypothesis 2: Irritability 
Sample Characteristics for the Irritability sample are presented in Table 5.  Of the irritability 
cohort, 51.25% reported suicidality.  The second analysis assessed the role of irritability as a 
risk factor for suicidality.  A multivariate binary logistic regression analysis was conducted, 
undergoing four iterations: Model 1 included irritable as a sole predictor; Model 2 adjusted 
for sociodemographic factors; Model 3 adjusted for all, bar depression, co-occurring 
diagnoses; Model 4 adjusted for psychotropic medications (see Table 6). 
After adjusting for sociodemographic factors, co-occurring diagnoses and psychotropic 
SUICIDALITY RISK FACTORS ADOLESCENTS WITH ASD 
81 
 
Table 4 
Multivariate Binary Logistic Regression Analysis of the Association between Suicidality and Depression in adolescents with ASD. 
 
 OR p-value aOR p-value aOR p-value
 
aOR p-value
6.58 4.33 9.99 <.001 4.86 3.08 7.68 <.001 4.08 2.54 6.54 <.001 3.18 1.94 5.21 <.001
Female
Male 0.53 0.39 0.71 <.001 0.54 0.40 0.73 <.001 0.56 0.41 0.77 <.001
1.04 0.96 1.13 0.36 1.02 0.94 1.11 0.60 1.01 0.93 1.11 0.76
White
Black 0.66 0.45 0.96 0.031 0.70 0.47 1.05 0.084 0.75 0.50 1.13 0.17
Asian 0.89 0.47 1.70 0.73 0.87 0.45 1.70 0.69 0.91 0.46 1.79 0.78
Mixed 0.95 0.60 1.51 0.84 0.95 0.60 1.53 0.85 1.02 0.63 1.64 0.94
Other or Not stated 0.45 0.23 0.87 0.019 0.50 0.25 0.99 0.048 0.55 0.27 1.10 0.09
Least deprived
Moderately deprived 0.84 0.60 1.17 0.31 0.82 0.58 1.16 0.26 0.83 0.59 1.18 0.30
Most deprived 0.91 0.65 1.28 0.60 0.89 0.62 1.27 0.52 0.95 0.66 1.36 0.77
Caregiver Mental health 
difficulties 1.73 1.26 2.37 0.001 1.53 1.11 2.13 0.01 1.54 1.10 2.14 0.011
Anxiety Disorder 1.43 0.61 3.34 0.41 1.18 0.49 2.81 0.71
Psychosis 3.04 1.85 5.00 <.001 2.15 1.25 3.68 0.005
Conduct Disorder 1.26 0.80 2.00 0.32 1.11 0.69 1.80 0.66
Tic Disorder 0.85 0.31 2.36 0.76 0.84 0.30 2.36 0.75
Eating Disorder 1.53 0.44 5.34 0.50 1.55 0.44 5.47 0.50
OCD 1.65 0.91 3.00 0.10 1.25 0.67 2.33 0.48
ADHD 0.90 0.63 1.30 0.59 0.87 0.60 1.26 0.46
Intellectual Disability 0.36 0.24 0.52 <.001 0.33 0.22 0.49 <.001
Antidepressant use 2.08 1.39 3.11 <.001
Antipsyhotic use 1.56 1.06 2.30 0.025
Family Characteristics
Psychotropic Medication
95% Confidence 
Interval
95% Confidence 
Interval
95% Confidence 
Interval
95% Confidence 
Interval
Age at ASD Diagnosis
Reference Reference
Co-occurring Neurodevelopmental Disorders
Sex
Ethnicity
Reference
Level of neighbourhood deprivation
Co-occurring Psychological Disorders
Reference
Model 2: Adjusting for Sociodemographic 
Factors
Model 3: Adjusting for Co-occurring 
Diagnoses Model 4: Fully Adjusted Model
Variable
Depression
Model 1: Crude Model
Reference Reference
Reference Reference Reference
Pseudo r-square 
Chi-square
5.40%
90.34, df=1, p<.001.
8.71% 13.10% 14.53%
118.82, df=10, p<.001. 177.99, df=18, p<.001. 198.16, df=20, p<.001.
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Table 5 
Sociodemographic and Clinical Characteristics of irritability cohort. 
Sample Characteristic 
Total Sample (n=480) 
Test statistic 
value (df) p-value 
Percentage 
of Total 
Cohort 
Non-Suicidal 
Sample 
(n=234) 
Suicidal 
Sample 
(n=246) 
Sex 
 Male 181 (77.35) 143 (58.13) χ
2 (1)=20.20 <.001 47.23% 
 Female 53 (22.65) 103 (41.87)   82.54% 
Age at ASD diagnosis, mean (SD) 15.14 (1.75) 15.20 (1.63) t (478)= -0.39 0.69  
Age of first contact with services, 
mean (SD) 15.32 (1.43) 15.23 (1.32) t (400)= 0.62 0.53  
Age at first report of suicidality, 
mean (SD) N/A 15.42 (1.38)    
Ethnicity 
 White 148 (63.25) 168 (68.29) χ
2 (4)=6.89 0.14 64.23% 
 Black 47 (20.09) 37 (15.04)   48.55% 
 Asian 10 (4.27) 12 (4.88)   55.00% 
 Mixed 13 (5.56) 21 (8.54)   43.59% 
 Other or Not stated 16 (6.84) 8 (3.25)   26.09% 
Level of neighbourhood deprivation 
 Least deprived 77 (35.32) 96 (41.03) χ
2 (2)=1.65 0.44 54.23% 
 Moderately deprived 73 (33.49) 74 (31.62)   61.25% 
 Most deprived 68 (31.19) 64 (27.35)   52.38% 
Caregiver mental health difficulties 43 (22.16) 73 (31.33) χ2 (1)=4.49 0.034 45.85% 
Medication 
 Antidepressant 40 (17.09) 96 (39.02) χ
2 (1)=28.40 <.001 69.74% 
 Antipsychotic 78 (33.33) 102 (41.46) χ
2 (1)=3.38 0.07 64.52% 
Co-occurring Psychological Disorders 
 Depression 19 (8.12) 65 (26.42) χ
2 (1)=27.83 <.001 68.29% 
 Anxiety Disorder 6 (2.56) 12 (4.88) χ
2 (1)=1.78 0.18 58.06% 
 Psychosis 19 (8.12) 59 (23.98) χ
2 (1)=22.18 <.001 70.91% 
 Conduct Disorder 29 (12.39) 32 (13.01) χ
2 (1)=0.04 0.84 45.19% 
 Eating Disorder 3 (1.28) 6 (2.44) χ
2 (1)=0.87 0.35 56.25% 
 Tic Disorder 2 (0.85) 4 (1.63) χ
2 (1)=0.58 0.45 30.00% 
 OCD 14 (5.98) 25 (10.16) χ
2 (1)=2.81 0.09 54.17% 
Co-occurring Neurodevelopmental Disorders 
 ADHD 61 (26.07) 56 (22.76) χ
2 (1)=.71 0.40 43.17% 
 
Intellectual 
Disability 74 (31.62) 32 (13.01) χ2 (1)=24.15 <.001 42.57% 
Baseline function 
 
CGAS Score, mean 
(SD) 43.07 (15.79) 47.29 (13.24) t (448)=-1.78 0.002  
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Table 6 
Multivariate Binary Logistic Regression Analysis of the Association between Suicidality and Irritability in adolescents with ASD. 
 
 OR p-value aOR p-value aOR p-value aOR p-value
 
aOR p-value
3.49 2.74 4.44 <.001 3.37 2.56 4.44 <.001 3.06 2.28 4.097043 <.001 2.61 1.92 3.54 <.001 2.47 1.82 3.37 <.001
Female
Male 0.51 0.38 0.68 <.001 0.52 0.38 0.70888 <.001 0.55 0.40 0.76 <.001 0.57 0.41 0.78 <.001
1.05 0.96 1.14 0.30 1.03 0.94 1.119124 0.56 1.02 0.93 1.11 0.69 1.01 0.92 1.10 0.84
White
Black 0.73 0.50 1.08 0.11 0.74 0.49 1.100628 0.14 0.77 0.51 1.16 0.21 0.77 0.51 1.16 0.21
Asian 0.99 0.51 1.90 0.97 0.93 0.48 1.82019 0.83 0.97 0.49 1.91 0.92 0.92 0.46 1.84 0.81
Mixed 1.17 0.73 1.86 0.52 1.12 0.69 1.805027 0.65 1.15 0.71 1.86 0.58 1.15 0.71 1.88 0.57
Other or Not stated 0.47 0.24 0.95 0.034 0.50 0.25 1.03 0.06 0.55 0.27 1.11 0.10 0.56 0.28 1.15 0.11
Least deprived
Moderately deprived 0.77 0.55 1.08 0.13 0.75 0.53 1.060066 0.10 0.76 0.54 1.09 0.13 0.77 0.54 1.10 0.15
Most deprived 0.85 0.60 1.21 0.37 0.81 0.57 1.167489 0.26 0.87 0.60 1.25 0.44 0.88 0.61 1.27 0.51
Caregiver Mental health difficulties 1.76 1.28 2.41 <.001 1.56 1.12 2.168969 0.010 1.54 1.10 2.15 0.01 1.48 1.05 2.07 0.024
Depression 2.83 1.71 4.68 <.001
Anxiety Disorder 1.38 0.59 3.21 0.46 1.12 0.47 2.66 0.80 1.06 0.44 2.54 0.89
Psychosis 2.41 1.45 4.00 <.001 1.96 1.13 3.37 0.02 1.91 1.10 3.32 0.023
Conduct Disorder 1.13 0.70 1.83 0.61 1.08 0.66 1.77 0.76 1.10 0.68 1.81 0.69
Eating Disorder 1.23 0.35 4.37 0.75 1.32 0.37 4.72 0.67 0.94 0.33 2.66 0.90
Tic Disorder 1.24 0.34 4.51 0.88 0.90 0.31 2.58 0.84 1.29 0.35 4.69 0.70
OCD 1.32 0.72 2.40 0.37 1.05 0.56 1.96 0.88 1.14 0.61 2.14 0.69
ADHD 0.79 0.55 1.15 0.22 0.79 0.54 1.15 0.23 0.83 0.57 1.21 0.34
Intellectual Disability 0.33 0.22 0.48 <.001 0.33 0.22 0.48 <.001 0.34 0.23 0.50 <.001
Antidepressant use 2.12 1.43 3.16 <.001 1.71 1.13 2.60 0.011
Antipsychotic use 1.23 0.83 1.83 0.30 1.24 0.83 1.86 0.28
Variable
Model 1: Crude Model
Model 2: Adjusting for Sociodemographic 
Factors
Model 3: Adjusting for Co-occurring 
Diagnoses
Model 4: Adjusting for Psychotropic 
medication
95% Confidence 
Interval
95% Confidence 
Interval
95% Confidence 
Interval
95% Confidence 
Interval
Irritability
Reference Reference Reference
Sex
Age at ASD Diagnosis
Reference Reference Reference
Ethnicity
Level of neighbourhood deprivation
Family Characteristics
Co-occurring Psychological Disorders
Co-occurring Neurodevelopmental Disorders
Pseudo r-square 6.37% 10.53% 14.52% 15.68%
Medication
Reference Reference Reference
231.16, df=21, p<.001.Chi-square 106.67, df=1, p<.001. 143.70, df=10, p<.001. 198.11, df=18, p<.001. 213.94, df=20, p<.001.
Reference
Reference
Reference
16.95%
95% Confidence 
Interval
Model 5: Full Model after adjusting for 
Depression
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medication, irritability was found to be significantly associated with suicidality (OR 2.61, 
1.92-3.54).  In terms of sociodemographic factors, there was a significant association 
identified with gender (OR 0.55, 0.40-0.76), with females more likely to report suicidality; 
additionally, having a caregiver with mental health difficulties was also significantly 
associated with suicidality (OR 1.54, 1.10-2.15).  Psychotic disorder was the only 
psychological disorder found to be associated with suicidality (OR 1.96, 1.13-3.37), whilst ID 
was found to have a negative association (OR 0.33, 0.22-0.48), with individuals significantly 
less likely to be in the suicidal group.  Lastly, in terms of medication, only antidepressants 
were found to be associated with suicidality (OR 2.12, 1.43-3.16). 
Hypothesis 3: Depression & Irritability 
Depression was added to the final model (Model 5; see Table 6), in order to establish whether 
irritability remained a significant predictor of suicidality after controlling for depression (see 
Table 6).  Even after controlling for depression, irritability remained significantly associated 
with suicidality (OR 2.47, 1.82-3.37).  Gender continued to have a significant association 
with suicidality (OR 0.57, 0.41-0.78), with suicidality more likely amongst females; caregiver 
mental health was also a significant predictor of suicidality (OR 1.48, 1.05-2.07).  Psychotic 
disorder was the only psychological disorder found to have significant association (OR 1.91, 
1.10-3.32), whilst ID was found to have a negative association (OR 0.33, 0.22-0.48), with the 
likelihood of suicidality being significantly lower for those with an ID diagnosis.  
Antidepressants were also found to be associated with suicidality (OR 2.12, 1.43-3.16). 
Hypothesis 4: Individual Profiles  
Sample characteristics are presented in Table 7.  The final research question investigated the 
relationship between suicidality and the three distinct profiles: DWI, DNI, and IND.  The 
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analysis underwent two phases, the first examining the role of each profile as a predictor for 
suicidality, the second comparing each profile with the other.  For the first phase, a 
multivariate binary logistic regression analysis was conducted, undergoing six iterations: 
Model 1 included DWI as a sole predictor; Model 2 adjusted for DNI; Model 3 adjusted for 
IND; Model 4 adjusted for sociodemographic factors; Model 5 adjusted for all other co-
occurring diagnoses; Model 6 was the final iteration, including psychotropic medications (see 
Table 8). 
Significant associations with suicidality were found for all three profiles: DNI (OR 7.51, 
2.69-20.96), DWI (OR 4.53, 2.56-8.03), and IND (OR 2.70, 1.96-3.74).  Of the 
sociodemographic factors, gender was found to be significant, with suicidality more likely 
amongst females (OR 0.57, 0.41-0.78), as well as caregiver mental health difficulties (OR 
1.45, 1.03-2.03).  Psychotic disorder was the only psychological disorder found to have 
significant association (OR 1.95, 1.12-3.39), whilst ID was found to have a negative 
association (OR 0.34, 0.23-0.50), with the likelihood of suicidality being significantly lower 
for those with an ID diagnosis.  Antidepressant use was also found to be associated with 
suicidality (OR 2.12, 1.43-3.16). 
In order to compare relationship to suicidality between profiles, a composite dummy variable 
was created using DWI as the reference group.  The dummy variable was included in a 
multivariate binary logistic regression analysis, which underwent four iterations: Model 1 
consisted of the profile composite variable only; Model 2 adjusted for sociodemographic 
factors; Model 3 further adjusted for the remaining disorders; Model 4 was the final iteration, 
including psychotropic medications (see Table 9). 
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Table 7 
Sociodemographic and Clinical Characteristics of for each profile presentation.  
Sample Characteristic 
Depression with Co-occurring Irritability Depression without Co-occurring Irritability Irritability without Co-occurring Depression 
Total Sample (n=34) 
Test statistic 
value (df) 
p-
value 
Total Sample (n=89) 
Test statistic 
value (df) 
p-
value 
Total Sample (n=396) 
Test statistic 
value (df) 
p-
value 
Non-Suicidal 
Sample (n=6) 
Suicidal 
Sample (n=28) 
Non-Suicidal 
Sample (n=27) 
Suicidal 
Sample (n=62) 
Non-Suicidal 
Sample (n=215) 
Suicidal 
Sample 
(n=181) 
Sex 
 Male 3 (50) 15 (53.57) χ
2 (1)=0.025 0.87 22 (81.48) 28 (45.16) χ2 (1)=10.08 0.001 166 (77.21) 113 (62.43) χ2 (1)=10.31 0.001 
 Female 3 (50) 13 (46.43)   5 (18.52) 34 (54.84)   49 (22.79) 68 (37.57)   
Age at ASD diagnosis, mean 
(SD) 14.71 (1.60) 15.37 (1.65) t (32)= -0.89 0.38 15.36 (1.67) 15.68 (1.30) t (87)= -0.99 0.33 15.16 (1.76) 15.08 (1.67) t (394)=0.42 0.68 
Age of first contact with 
services, mean (SD) 14.23 (1.08) 15.28 (1.30) t (30)= -1.69 0.10 15.52 (1.35) 15.59 (1.28) t (83)= -.22 0.83 15.36 (1.44) 15.13 (1.31) t (319)=1.47 0.14 
Age at first report of 
suicidality, mean (SD) N/A 15.26 (1.35)   N/A 15.60 (1.37)   N/A 15.40 (1.39)   
Ethnicity 
 White 3 (50) 21 (75) χ
2 (3)=5.61 0.13 19 (70.37) 39 (62.90) χ2 (4)=3.53 0.47 136 (63.26) 132 (67.96) χ2 (4)=5.92 0.21 
 Black 1 (16.67) 5 (17.86)   3 (11.11) 13 (20.97)   45 (20.93) 26 (14.36)   
 Asian 1 (16.67) 2 (7.14)   1 (3.70) 3 (4.84)   8 (3.72) 8 (4.42)   
 Mixed 0 (0) 0 (0)   3 (11.11) 7 (11.29)   11 (5.12) 16 (8.84)   
 Other or Not stated 1 (16.67) 0 (0)   1 (3.70) 0 (0)   15 (6.98) 8 (4.42)   
Level of neighbourhood deprivation 
 Least deprived 3 (60) 11 (44) χ
2 (2)=1.51 0.47 10 (40) 25 (42.37) χ2 (2)=0.09 0.96 70 (35.00) 72 (41.38) χ2 (2)=1.71 0.42 
 Moderately deprived 2 (40) 8 (32)   8 (32) 17 (28.81)   66 (33.00) 54 (31.03)   
 Most deprived 0 (0) 6 (24)   7 (28) 17 (28.81)   64 (32.00) 48 (27.59)   
Caregiver mental health 
difficulties 4 (80) 12 (42.86) χ2 (1)=2.34 0.13 7 (26.92) 18 (30.00) χ2 (1)=.08 0.77 36 (20.45) 53 (31.36) χ2 (1)=5.36 0.021 
Medication 
 Antidepressant 2 (33.33) 15 (53.57) χ
2 (1)=0.81 0.37 11 (40.74) 38 (61.29) χ2 (1)=3.21 0.07 32 (14.88) 52 (28.73) χ2 (1)=11.27 0.001 
 Antipsychotic 2 (33.33) 10 (35.71) χ
2 (1)=0.01 0.91 12 (44.44) 15 (24.19) χ2 (1)=3.65 0.06 68 (31.63) 78 (43.09) χ2 (1)=5.55 0.018 
Co-occurring Psychological Disorders 
 Anxiety Disorder 1 (16.67) 0 (0) χ
2 (1)=4.80 0.028 3 (11.11) 3 (4.84) χ2 (1)=1.18 0.28 3 (1.40) 9 (4.97) χ2 (1)4.28 0.039 
 Psychosis 2 (33.33) 10 (35.71) χ
2 (1)=0.01 0.91 4 (14.81) 11 (17.74) χ2 (1)=0.12 0.74 13 (6.05) 40 (22.10) χ2 (1)=21.85 <.001 
 Conduct Disorder 0 (0) 2 (7.14) χ
2 (1)=0.46 0.50 4 (14.81) 5 (8.06) χ2 (1)=0.94 0.33 27 (12.56) 26 (14.36) χ2 (1).28 0.6 
 Eating Disorder 0 (0) 0 (0)   0 (0) 2 (3.23) χ
2 (1)=0.89 0.35 3 (1.40) 4 (2.21) χ2 (1)=0.38 0.54 
 Tic Disorder 0 (0) 0 (0) χ
2 (1)=.40 0.53 1 (3.70) 0 (0) χ2 (1)=2.32 0.13 2 (0.93) 4 (2.21) χ2 (1)=1.08 0.3 
 OCD 0 (0) 0 (0) χ
2 (1)=11.07 0.001 4 (14.81) 5 (8.06) χ2 (1)=0.94 0.33 11 (5.12) 20 (11.05) χ2 (1)=4.79 0.029 
Co-occurring Neurodevelopmental Disorders 
 ADHD 2 (33.33) 3 (10.71) χ2 (1)=2.02 0.16 6 (22.22) 6 (9.68) χ2 (1)=2.54 0.11 55 (25.58) 49 (27.07) χ2 (1)=.11 0.74 
 Intellectual Disability 0 (0) 1 (.57) χ2 (1)=0.22 0.64 8 (29.63) 6 (9.68) χ2 (1)=5.65 0.017 70 (32.56) 28 (15.47) χ2 (1)=15.41 <.001 
Baseline function 
  CGAS Score, mean (SD) 45.00 (4.24) 52.33 (12.60) t (31)=-1.39 0.17 43.81 (13.93) 49.47 (10.23) t (86)= -2.12 0.037 43.23 (15.99) 45.97 (13.65) t (365)= -1.76 0.08 
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predictor for suicidality, the second comparing each profile with the other.  For the first 
phase, a multivariate binary logistic regression analysis was conducted, undergoing six 
iterations: Model 1 included DWI as a sole predictor; Model 2 adjusted for DNI; Model 3 
adjusted for IND; Model 4 adjusted for sociodemographic factors; Model 5 adjusted for all 
other co-occurring diagnoses; Model 6 was the final iteration, including psychotropic 
medications (see Table 8). 
Significant associations with suicidality were found for all three profiles: DNI (OR 7.51, 
2.69-20.96), DWI (OR 4.53, 2.56-8.03), and IND (OR 2.70, 1.96-3.74).  Of the 
sociodemographic factors, gender was found to be significant, with suicidality more likely 
amongst females (OR 0.57, 0.41-0.78), as well as caregiver mental health difficulties (OR 
1.45, 1.03-2.03).  Psychotic disorder was the only psychological disorder found to have 
significant association (OR 1.95, 1.12-3.39), whilst ID was found to have a negative 
association (OR 0.34, 0.23-0.50), with the likelihood of suicidality being significantly lower 
for those with an ID diagnosis.  Antidepressant use was also found to be associated with 
suicidality (OR 2.12, 1.43-3.16). 
In order to compare relationship to suicidality between profiles, a composite dummy variable 
was created using DWI as the reference group.  The dummy variable was included in a 
multivariate binary logistic regression analysis, which underwent four iterations: Model 1 
consisted of the profile composite variable only; Model 2 adjusted for sociodemographic 
factors; Model 3 further adjusted for the remaining disorders; Model 4 was the final iteration, 
including psychotropic medications (see Table 9). 
After adjusting for covariates, the analysis found that the only significant difference in 
relationship to suicidality between profiles was between DWI and IND, with those with 
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Table 8 
Multivariate Binary Logistic Regression Analysis of the Association between Suicidality and Individual Profiles in adolescents with ASD. 
 
Variable 
Model 1: Crude Model 
Model 2: Adjusting for Depression 
without Co-occurring Irritability 
Model 3: Adjusting for Irritability 
without Co-occurring Depression 
Model 4: Adjusting for 
Sociodemographic Factors 
Model 5: Adjusting for All Co-
occurring Diagnoses Model 6: Fully Adjusted Model 
 OR 
95% 
Confidence 
Interval 
p-
value 
 
aOR 
95% Confidence 
Interval p-value 
 
aOR 
95% Confidence 
Interval p-value 
 
aOR 
95% 
Confidence 
Interval 
p-
value 
 
aOR 
95% 
Confidence 
Interval 
p-
value 
  
aOR 
95% 
Confidence 
Interval 
p-
value 
Profiles             
 
Depression with Co-
occurring Irritability 9.87 4.05 24.02 <.001 11.26 4.62 27.43 <.001 17.42 7.10 42.75 <.001 13.49 4.97 36.56 <.001 9.37 3.41 25.75 <.001 7.51 2.69 20.96 <.001 
 
Depression without 
Co-occurring 
Irritability     5.54 3.47 8.85 <.001 8.57 5.29 13.89 <.001 6.66 3.93 11.28 <.001 5.75 3.34 9.91 <.001 4.53 2.56 8.03 <.001 
 
Irritability without 
Co-occurring 
Depression         3.14 2.42 4.08 <.001 3.19 2.36 4.29 <.001 3.01 2.20 4.11 <.001 2.70 1.96 3.74 <.001 
Sex 
 Female       Reference Reference Reference 
 Male             0.54 0.40 0.73 <.001 0.55 0.40 0.76 <.001 0.57 0.41 0.78 <.001 
Age at ASD Diagnosis             1.02 0.94 1.12 0.59 1.01 0.92 1.10 0.84 1.01 0.92 1.10 0.91 
Ethnicity 
 White       Reference Reference Reference 
 Black             0.72 0.49 1.06 0.10 0.74 0.49 1.11 0.15 0.77 0.51 1.16 0.21 
 Asian             0.94 0.48 1.85 0.87 0.90 0.45 1.80 0.77 0.94 0.47 1.87 0.85 
 Mixed             1.19 0.74 1.91 0.48 1.16 0.71 1.89 0.55 1.19 0.73 1.94 0.49 
 Other or Not stated             0.50 0.25 1.00 0.05 0.53 0.26 1.08 0.08 0.56 0.27 1.14 0.11 
Level of neighbourhood deprivation 
 Least deprived       Reference Reference Reference 
 Moderately deprived             0.78 0.56 1.11 0.17 0.76 0.54 1.09 0.14 0.77 0.54 1.11 0.16 
 Most deprived             0.88 0.62 1.25 0.48 0.85 0.59 1.22 0.37 0.89 0.61 1.28 0.52 
Family Characteristics 
 
Caregiver Mental 
health difficulties             1.61 1.16 2.23 <.001 1.44 1.03 2.02 0.033 1.45 1.03 2.03 0.034 
Co-occurring Psychological Disorders 
 Anxiety Disorder                 1.26 0.53 3.00 0.60 1.11 0.46 2.65 0.82 
 Psychosis                 2.33 1.39 3.90 <.001 1.95 1.12 3.39 0.018 
 Conduct Disorder                 1.17 0.72 1.88 0.53 1.11 0.68 1.81 0.69 
 Eating Disorder                 0.94 0.33 2.68 0.90 0.92 0.32 2.63 0.88 
 Tic Disorder                 1.26 0.35 4.54 0.72 1.32 0.37 4.74 0.67 
 OCD                 1.39 0.75 2.56 0.29 1.16 0.62 2.18 0.64 
Co-occurring Neurodevelopmental Disorders 
 ADHD                 0.84 0.58 1.23 0.37 0.83 0.57 1.21 0.34 
 
Intellectual 
Disability                 0.34 0.23 0.51 <.001 0.34 0.23 0.50 <.001 
Medication 
 Antidepressant use                     1.73 1.14 2.62 0.010 
 Antipsychotic use                     1.24 0.83 1.85 0.29 
Pseudo r-square  2.12% 5.52% 9.99% 13.17% 16.64% 17.26% 
Χ-square 35.56, df=1, p<.001. 92.48, df=2, p<.001. 167.20, df=3, p<.001. 179.59, df=12, p<.001. 226.96, df=20, p<.001. 235.42, df=22, p<.001. 
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Table 9 
Multivariate Binary Logistic Regression Analysis comparing strength of Association between Suicidality and Individual Profiles in adolescents 
with ASD. 
Variable 
Model 1: Crude Model Model 2: Adjusting for Sociodemographic Factors 
Model 3: Adjusting for All Co-occurring 
Diagnoses Model 4: Fully Adjusted Model 
 OR 
95% Confidence 
Interval 
p-
value 
 
aOR 
95% Confidence 
Interval p-value 
 
aOR 
95% Confidence 
Interval p-value 
  
aOR 
95% Confidence 
Interval 
p-
value 
Profiles 
 
Depression with Co-occurring 
Irritability Reference Reference Reference Reference 
 
Depression without Co-occurring 
Irritability 0.49 0.18 1.33 0.16 0.48 0.16 1.46 0.20 0.60 0.20 1.86 0.38 0.59 0.19 1.84 0.37 
 
Irritability without Co-occurring 
Depression 0.18 0.07 0.45 <.001 0.23 0.08 0.63 <.001 0.30 0.11 0.85 0.023 0.34 0.12 0.98 0.047 
Sex 
 Female     Reference Reference Reference 
 Male     0.44 0.28 0.69 <.001 0.51 0.32 0.81 <.001 0.54 0.34 0.86 0.01 
Age at ASD Diagnosis     0.95 0.83 1.08 0.41 0.91 0.80 1.04 0.18 0.91 0.79 1.04 0.17 
Ethnicity 
 White     Reference Reference Reference 
 Black     0.91 0.51 1.62 0.75 0.89 0.48 1.63 0.71 0.97 0.52 1.78 0.91 
 Asian     1.04 0.40 2.75 0.93 1.02 0.38 2.76 0.97 1.11 0.40 3.04 0.84 
 Mixed     1.60 0.70 3.69 0.27 1.69 0.71 4.03 0.24 1.73 0.71 4.17 0.23 
 Other or Not stated     0.35 0.11 1.09 0.07 0.36 0.11 1.14 0.08 0.38 0.12 1.22 0.10 
Level of neighbourhood deprivation 
 Least deprived     Reference Reference Reference 
 Moderately deprived     0.73 0.44 1.19 0.21 0.73 0.44 1.22 0.23 0.74 0.44 1.24 0.25 
 Most deprived     0.95 0.57 1.59 0.84 0.95 0.56 1.64 0.86 0.99 0.57 1.72 0.98 
Family Characteristics 
 
Caregiver Mental health 
difficulties     1.55 0.97 2.46 0.07 1.35 0.83 2.19 0.22 1.31 0.80 2.14 0.28 
Co-occurring Psychological Disorders 
 Anxiety Disorder         1.18 0.39 3.52 0.77 1.08 0.36 3.27 0.89 
 Psychosis         2.72 1.44 5.16 <.001 2.37 1.16 4.83 0.018 
 Conduct Disorder         0.98 0.51 1.91 0.96 0.98 0.50 1.95 0.96 
 Eating Disorder         1.24 0.26 5.96 0.79 1.34 0.28 6.48 0.71 
 Tic Disorder         1.07 0.21 5.50 0.94 1.04 0.21 5.28 0.96 
 OCD         1.27 0.58 2.75 0.55 1.02 0.46 2.27 0.97 
Co-occurring Neurodevelopmental Disorders 
 ADHD         1.00 0.59 1.68 0.99 0.98 0.58 1.67 0.95 
 Intellectual Disability         0.42 0.25 0.70 <.001 0.41 0.24 0.72 <.001 
Medication 
 Antidepressant use             1.86 1.13 3.07 0.015 
 Antipsychotic use             1.11 0.66 1.85 0.70 
Pseudo r-square  4.38% 7.74% 11.42% 12.48% 
Χ-square 31.49, df=2, p<.001. 46.23, df=11, p<.001. 68.26, df=19, p<.001. 74.61, df=21, p<.001. 
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After adjusting for covariates, the analysis found that the only significant difference in 
relationship to suicidality between profiles was between DWI and IND, with those with IND 
significantly less likely to be report suicidality than their DWI counterparts (OR 0.34, 0.12-
0.98).  Gender continued to be significant (OR 0.54, 0.34-0.86); however, caregiver mental 
health was no longer significant (OR 1.31, 0.80-2.14).  Psychotic disorder remained the only 
other psychological disorder to be associated with suicidality (OR 2.37, 1.16-4.83), whilst ID 
was negatively associated with suicidality (OR 0.41, 0.24-0.72).  Antidepressant use was 
associated with suicidality (OR 1.86, 1.13-3.07). 
Discussion 
The aim of the study was to identify risk factors for suicidality in adolescents with ASD, 
specifically exploring the roles of depression and irritability as potential risk factors.  
Furthermore, this study compared the relationship between suicidality and individual 
depressive and irritability profiles.  The key findings are presented and interpreted below, 
followed by discussion of the study’s strengths and limitations, and the implications, both 
research and clinical, of the findings. 
 91 
 
Summary and Interpretations of Key Findings 
Hypothesis 1.  Depression is a risk factor for suicidality in adolescents with ASD. 
As expected, depression was found to be associated with suicidality, with an increased 
likelihood of suicidality for adolescents with ASD and co-occurring depression.  This finding 
is in keeping with the current research on suicidality in adolescents with ASD (Chen et al., 
2017; Mayes et al., 2013; Storch et al., 2013). It is also consistent with the findings of Pelton 
and Cassidy (2017), and the relationship between depression and suicidality proposed by 
IPTS (Silva et al., 2015). 
Hypothesis 2.  Irritability is a significant risk factor for suicidality in adolescents 
with ASD.  As predicted, irritability was found to have association with suicidality, with 
those reported with irritability more likely to report suicidality, which is consistent with 
Mayes at el. (2013), who found behavioural difficulties associated with poor emotional 
regulation to be a significant risk factor for suicidality in youth with ASD.  This finding is 
also consistent with IPTS, proposing labile mood to be associated with both thwarted 
belongingness and perceived burdensomeness (Silva et al., 2015).  
Hypothesis 3.  Part of the relationship, if not all, between irritability and 
suicidality will be explained by depression.  After controlling for depression in the 
regression model, the effect size for irritability reduced, but the association with suicidality 
remained significant.  This suggests that, whilst a proportion of initial association between 
irritability and suicidality was explained by depression, irritability may be a significant risk 
factor for suicidality in its own right.  
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Hypothesis 4.  Depression with co-occurring irritability (DWI) will be a stronger 
predictor for suicidality in adolescents with ASD than both depression without co-
occurring irritability (DNI) and irritability without co-occurring depression (IND).  This 
is the first study to investigate specific depressive and behavioural profiles as potential risk 
factors for suicidality in adolescents with ASD.  Analysis showed that both depressive 
profiles, DWI and DNI, were significant risk factors for suicidality, as was IND.  However, 
when comparing magnitude of respective effect sizes, DWI was only found to be 
significantly different than IND, with likelihood of suicidality significantly higher amongst 
individuals with DWI than IND.  There are several possible interpretations of these results.  
Firstly, the finding that individuals with DWI were significantly more likely than irritability 
without co-occurring depression to be suicidal suggests the presence of depression might 
intensify and increase the strength of association between irritability and suicidality.  
Secondly, the lack of difference found between DWI and DNI may indicate that DWI is not a 
stronger risk factor for suicidality than other depressive profiles; however, the DNI group was 
almost triple the size of the DWI cohort, and it is possible that the imbalance in group sizes 
may have impacted the analysis and obscured an actual difference that may have been visible 
had the groups matched in number. 
The analysis also identified significant associations between several of the covariates 
included.  Psychotic disorder was found to be significantly associated with suicidality 
throughout all statistical analyses after controlling for all other covariates.  Furthermore, the 
results suggest that its inclusion, alongside other psychological disorders, reduced the effect 
size of both depression and irritability, suggesting that some of their effect was partially 
explained by the presence of psychotic disorder.  Whilst no study has investigated psychotic 
disorder as a risk factor within this population, Karakoc Demirkaya, Tutkunkardas, and 
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Mukaddes (2016) reported significantly higher rates of psychotic features within their ASD 
suicidal sample.  Within the context of IPTS, Silva et al. (2015) found psychotic disorders to 
be associated with suicidality, predicting both perceived burdensomeness and Acquired 
Capability for Suicide. 
Surprisingly, the analysis found that female adolescents within the sample were almost twice 
as likely as male counterparts to report suicidality, which is contrary to the findings of Mayes 
et al. (2013), who reported being female to act as a protective factor against suicidality within 
their sample. A possible explanation for this is around increased vulnerability to depression:  
in typically-developing adolescents, the ratio of females to males affected by depression is 
2:1 (Birmaher et al., 1996), whilst females with ASD are more likely to display internalising 
difficulties, like depression (Mandy et al., 2012). With its strong association with suicidality, 
it may be that being at higher risk of depression increases likelihood of suicidality in female 
adolescents with ASD due to greater probability of exposure to said risk factor.  
Adolescents with co-occurring diagnoses of ID were significantly less likely to engage in 
suicidality.  To the best of the author’s knowledge, no previous study has reported a 
significant relationship between ID and suicidality in adolescents with ASD; however, 
Hardan and Sahl (1999) reported of their cohort of youth with developmental disorders, in 
which ASD was included, significantly lower rates of suicidality amongst those diagnosed 
with severe/profound mental retardation. Shtayermann (2007) reported severity of AS 
presentation to be negatively correlation with both suicidal ideation and peer victimisation, 
positing that individuals with more severe presentations might be more likely to receive 
support and supervision from teachers, reducing incidence of peer victimisation, and due its 
potential role as a proximal risk factor, reducing the likelihood of suicidal ideation. 
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Several of the analyses suggested that caregiver mental health difficulties may also be a risk 
factor for suicidality within this population.  This is the first study to the author’s knowledge 
to include caregiver mental health within the analysis; Karakoc Demirkaya et al. (2016) 
included both family history of lethal and nonlethal suicidal behaviours, and familial history 
of completed suicide, finding significantly higher rates within their suicidal sample, 
suggesting the role of family characteristics as risk factors. A possible explanation for this 
finding is that caregiver mental health may increase probability of an individual developing 
mental health difficulties which have already been identified as risk factors for suicidality in 
their own rights.  For example, within typically-developing samples, adolescents with a 
depressed parent are more likely develop depression by three to four times (Rice & Rawal, 
2011).   
Medication was consistently found to be related to suicidality, with taking antidepressants 
associated with increased likelihood of suicidality.  Furthermore, the inclusion of medication 
as a covariate appeared to reduce the size of effect for depression, irritability and psychotic 
disorder.  Whilst a potential interpretation is that antidepressant use increases probability of 
suicidality, it may be that any effect of medication observed is better explained by alternative, 
already existing risk factors.  For example, depressed individuals may be more likely to be 
prescribed antidepressants, and, given the role of depression as a risk factor for suicidality, 
part of the effect of antidepressants may actually be better explained by depression.  
However, it remains a possibility that there is a unique relationship between antidepressant 
use and suicidality, separate to any associated psychological disorder: whilst found to reduce 
incidence of suicidality in adult samples, antidepressants have been associated with an 
increased risk of suicidality in children and adolescents (Nischal, Tripathi, Nischal, & 
Trivedi, 2011). 
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Strengths and Limitations 
A strength of this study was the large sample size, which increased the power of statistical 
tests in detecting significant differences, reducing the probability of wrongly rejecting any of 
the research hypotheses.  Moreover, using data from the CRIS database allowed for rich 
variety of variables to be included and controlled for within the study, contributing to greater 
precision of analysis.  However, the study was also impacted by several limitations.  
Firstly, the construct of suicidality investigated in this study was a collective term 
encompassing suicidal ideation, behaviour and attempt.  Whilst using such a definition is 
arguably clinically useful, the inability to distinguish between different suicidal phenomena 
makes it difficult to fully generalise the role of the risk factors identified across all types of 
suicidality; for example, a risk factor associated with suicidal ideation may only be related to 
ideation, and thus have no association with suicidal behaviour whatsoever.  Mayes et al. 
(2013) found depression to be the single strongest predictor for suicidal ideation, but for 
suicide attempt the strongest predictors were suicidal ideation and mood dysregulation. 
Consequently, this study is limited by its use of suicidality as a collective term, as it is not 
possible to conclude from these results whether any of the associations found apply across all 
types of suicidality, or whether they relate to specific suicidal phenomena. 
This study employed a cross-sectional design: whilst effective in both determining prevalence 
of an outcome, and identifying significant associations between factors and outcomes, a 
limitation of this design is that it is impossible to infer causality between risk factors and 
outcomes (i.e. suicidality).  Consequently, it limits the conclusions able to be drawn from 
these findings.  In the cases of the relationship between suicidality and all psychological risk 
factors identified, it is possible that suicidal adolescents with ASD are more likely to develop 
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such phenomena; conversely, it may be that adolescents with these characteristics are more 
likely to present with some element of suicidality.  This study’s design means that 
conclusions around such questions cannot be inferred from these results, and therefore 
requires further longitudinal analysis to examine any temporal relationships. 
Whilst the richness of information available from the CRIS database was a strength of this 
study, it also acted as a potential limitation in terms of quality of data available.  A significant 
proportion of data extracted came from clinical records (progress notes, clinical 
correspondence, etc.), and whilst beneficial in terms of amount of data available, clinical 
records tend to be more subject to opinion and therefore at higher risk of reporting bias.  
Furthermore, this study investigated suicidality within a clinical population, and therefore it is 
unclear whether these findings can be generalised to community samples of autistic 
adolescents. 
Additionally, whilst the vast amount of data available allowed for the inclusion of multiple 
covariate variables, a limitation of cohort studies is that their observational nature makes it is 
difficult to control for the influence of unaccounted confounding variables.  Given that the 
highest proportion of variance accounted for by any of the statistical models analysed was 
17.26%, this suggests that there are still several unaccounted variables which may influence 
the relationship between ASD and suicidality in adolescents. 
This study employed an epidemiological approach, focusing on establishing both prevalence 
of suicidality and associated risk factors. Whilst this can be clinically useful, a limitation of 
this approach is that, in focusing solely on describing a population’s characteristics, it 
provides no insight into the causal processes mediating between risk factors and suicidality, 
which psychological theory seeks to explain . Consequently, a limitation of this study is that 
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its findings offer little contribution to theoretical literature on suicidality. Furthermore, testing 
of psychological theory within this study was limited by the data available: sample size and 
limited availability of qualitative data prevented the possibility of conducting qualitative 
analysis, which could be helpful in identifying causal processes. 
Research implications 
This study’s findings suggest several avenues for further research.  Firstly, the associations 
identified between suicidality and depression, irritability, and psychotic disorder, as well as 
depressive profiles, should be tested longitudinally using Cox Regression Analysis with 
Hazard Ratios for measures of effect size.  This study’s use of cross-sectional design, 
precludes inference of any causal relationship between these risk factors and suicidality, 
making longitudinal analysis essential to provide insight into the direction of relationship 
between factors and outcome e.g. whether depression precedes suicidality, or whether 
suicidal individuals are more likely to become depressed. 
The use of suicidality as a collective term encompassing both suicidal ideation and behaviour 
prevents both differentiation between risk factors specifically for ideation and those 
associated with behaviour, and establishment of shared risk factors between the two 
phenomena.  Future studies should investigate different aspects of suicidality as separate 
outcome variables to establish the nature of association between risk factors and individual 
suicidality presentations.  Isolating ideation and behaviour as separate outcome variables 
could also help test the validity of IPTS in explaining suicidal phenomena in this population, 
and a prospective cohort design would probably best suit this research goal. 
Future research should look at suicidal ideation as a possible risk factor for later suicidal 
behaviour.  Mayes et al. (2013) found suicidal ideation to be the strongest single risk factor 
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for suicide attempt amongst their sample of youth with ASD; therefore, it could be helpful to 
investigate, as part of a longitudinal analysis, suicidal ideation as a possible mediator between 
risk factors identified in this study and subsequent suicidal behaviour. 
Future study should aim to enhance understanding of causal mechanisms mediating 
relationships between risk factors and suicidality.  Further investigation into individual 
profiles, both depressive and psychotic, and their relationship with suicidality could shed 
light on such mechanisms.  Furthermore, future studies could attempt to investigate score 
profiles on validated psychometric measures and see how they may map onto different 
behavioural/psychological profiles to assist identification for such studies.  
Despite its efficacy in identifying risk factors, epidemiological approaches provide little 
insight into such mechanisms. Theory-driven research could complement findings of 
epidemiological studies and further aid understanding of such mechanisms. For example, 
testing IPTS with individuals identified in this study as high-risk (e.g. depressed adolescents), 
and investigating the roles of Thwarted Belongingness, Perceived Burdensomeness and 
Acquired Capability for Suicide could help improve understanding of possible causal 
mechanisms between risk factors and suicidality. This could be accomplished using a 
prospective longitudinal design, with multiple check-in points, to improve appropriateness 
and quality of data collected; moreover, a smaller cohort size should be used to allow for 
gathering and analysis of both quantitative and qualitative data. 
Another potential avenue could be specifically to investigate high-risk groups identified 
within this study (e.g. adolescents with ASD and co-occurring depression, irritability or 
psychotic disorder; individuals with caregivers with mental health difficulties), to further 
contribute to understanding of the causal processes mediating suicidality and psychological 
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factors.   
Lastly, given the target population were adolescents, it is unclear whether these findings 
would be applicable for younger children with ASD: risk factors for suicidality may differ in 
a younger cohort, and therefore future study could benefit from including children alongside 
an adolescent sample. 
Clinical implications 
These findings identify several areas for development of clinical practice.  Firstly, these 
findings could help inform development of existing risk assessment protocol with the aim of 
minimising either risk of, or preventing escalation of, suicidality in adolescents with ASD.  
Those identified to be at high risk for suicidality (e.g. depressed adolescents) may benefit 
from more frequent risk assessment by services in order to reduce the likelihood of suicidality 
going unnoticed and therefore potentially escalating to engagement in life-threatening 
behaviours.  Additionally, those noted to have increased irritability may benefit from 
psychological assessment, given its association with a range of psychological disorders in 
children and adolescents (McLaughlin et al., 2011), as well as impromptu risk screening.  
This type of early identification could help ensure that those requiring intervention do not get 
overlooked and receive appropriate support in a timely manner.  Increased contact could also 
help gather more information about an individual’s situation, which could add to their 
formulation and better inform development of appropriate person-centred intervention; 
should this process identify caregiver mental health difficulties, clinicians could consider 
including psychological support for caregivers as part of an intervention centred on the young 
person.  
Identifying high-risk individuals would also be useful as it would allow for those involved in 
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an individual’s care, professionals and family members alike, to be provided training in both 
identifying and managing the emergence of and/or increases in levels of risk or suicidality, 
hopefully reducing opportunity for escalation. 
These findings could help inform development of interventions targeting suicidality.  Using 
frameworks such as IPTS to understand the nature of the relationship between risk factors 
and suicidality could help inform the development of more bespoke interventions; for 
example, if depression is associated with Thwarted Belongingness and Perceived 
Burdensomeness, an intervention designed to reduce the likelihood of these experiences 
could be instrumental in reducing the likelihood of suicidality for autistic adolescents with 
co-occurring depression.  
Conclusion 
In conclusion, the aim of this study was to identify risk factors for suicidality in adolescents 
with ASD.  Specifically, it sought to understand the roles of depression and irritability as 
potential risk factors for suicidality with this population.  This was the first study to 
investigate suicidality and ASD in a UK adolescent clinical cohort.  It was also the first study 
to compare different profiles (DWI, DNI, IND) and the potential associations with 
suicidality.  Cross-sectional analysis indicated a positive association between suicidality and 
depression, as well as with irritability even after controlling for the effect of depression.  
With regards to difference between individual profiles, a difference was identified between 
depression with co-occurring irritability and irritability without co-occurring depression only, 
with depression with co-occurring irritability increasing likelihood of suicidality.  The results 
also suggested that psychotic disorders are associated with increased likelihood of suicidality, 
as well as being female, having a caregiver with mental health difficulties, and taking 
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antidepressants, whilst a diagnosis of ID was found to be negatively associated with 
suicidality.  The findings also appear to provide preliminary support for the use of the IPTS 
model in understanding the suicidality in adolescents with ASD.  Future research may wish to 
repeat this study using a longitudinal design in order to better understand the nature of the 
temporal relationship between risk factors and suicidality.  Furthermore, studies may wish to 
explore the relationship between suicidality and distinct profiles, as well as investigating the 
high-risk groups identified here, to increase knowledge around causal mechanisms at play.  
Lastly, these findings have implications for clinical practice, informing both the review of 
existing risk management protocols, as well as the development of specific interventions 
designed to prevent or minimise risk of suicidality in adolescent with ASD.  
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Appendix A: Search terms using in Review 
PsychInfo: 
1. autis*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures]  
2. asd.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures]  
3. autistic disorder.mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures]  
4. asperger*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
5. autistic spectrum disorder.mp. [mp=title, abstract, heading word, table of contents, 
key concepts, original title, tests & measures]  
6. pervasive developmental disorder.mp. [mp=title, abstract, heading word, table of 
contents, key concepts, original title, tests & measures]  
7. pdd-nos.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
8. (pervasive developmental disorder not otherwise specified).mp. [mp=title, abstract, 
heading word, table of contents, key concepts, original title, tests & measures]  
9. asperger's syndrome.mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures]  
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10. aspergers syndrome.mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures]  
11. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10  
12. suicid*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
13. exp Drug Overdoses/  
14. parasuicid*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
15. overdos*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
16. drug overdos*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
17. self poison*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
18. ligature*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
19. exp Suicide/  
20. exp Suicidal Ideation/  
21. exp Attempted Suicide/  
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22. selfpoison*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
23. hanging*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
24. 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23   
25. child*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures]  
26. adolescen*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
27. youth.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures]  
28. (young adj (people or person)).mp. [mp=title, abstract, heading word, table of 
contents, key concepts, original title, tests & measures]  
29. teen*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures]  
30. p?ediatric.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
31. young adult*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
32. 25 or 26 or 27 or 28 or 29 or 30 or 31 
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33. 11 and 24 and 32 
Medline: 
1. child*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
2. adolescen*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms]  
3. youth.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
4. (young adj (people or person)).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier, synonyms]  
5. teen*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
6. p?ediatric.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms]  
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7. Young Adult/  
8. young adult*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms]  
9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8  
10. autis*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
11. asd.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
12. autistic disorder.mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, 
rare disease supplementary concept word, unique identifier, synonyms]  
13. asperger*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms]  
14. autistic spectrum disorder.mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier, synonyms]  
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15. pervasive developmental disorder.mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier, synonyms]  
16. pdd-nos.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms]  
17. (pervasive developmental disorder not otherwise specified).mp. [mp=title, abstract, 
original title, name of substance word, subject heading word, keyword heading word, 
protocol supplementary concept word, rare disease supplementary concept word, 
unique identifier, synonyms]  
18. asperger's syndrome.mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, 
rare disease supplementary concept word, unique identifier, synonyms]  
19. aspergers syndrome.mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, 
rare disease supplementary concept word, unique identifier, synonyms]  
20. autistic disorder.sh.  
21. 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20  
22. suicid*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms]  
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23. exp Drug Overdoses/  
24. parasuicid*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms]  
25. overdos*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms]  
26. drug overdos*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms]  
27. self poison*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms]  
28. ligature*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms]  
29. exp Suicide/  
30. exp Suicidal Ideation/  
31. exp Attempted Suicide/  
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32. selfpoison*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms]  
33. hanging*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms]  
34. suicide.sh.  
35. 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33  
36. 9 and 21 and 35 
Web of Science: 
1. TS=(child* OR adolescen* OR youth OR young person OR young people OR teen* OR 
pediatric OR paediatric OR young adult)  
DocType=All document types; Language=All languages 
2. TS=(autis* OR autism OR asd OR autistic disorder OR asperger* OR autistic spectrum 
disorder OR pervasive developmental disorder OR pdd-nos OR pervasive developmental 
disorder not otherwise specified OR aspergers syndrome OR asperger's syndrome)  
DocType=All document types; Language=All languages; 
3. TS=(suicid* OR drug overdos* OR overdos* OR parasuicid* OR self poison* OR self-
poison* OR selfpoison* OR ligature* OR suicidal ideation OR suicide attempt* OR 
hanging*)  
DocType=All document types; Language=All languages; 
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Appendix B: CASP Framework for cohort studies (CASP, 2017) 
This has been removed from the electronic copy 
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Appendix C: NHS Ethics Approval 
This has been removed from the electronic copy 
  
 123 
 
 
Appendix D: CRIS Ethics Application & Approval 
This has been removed from the electronic copy  
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Appendix E: End of study report 
Suicidality in adolescents with Autism Spectrum Disorders: investigating Depression 
and Irritability as risk factors in a UK clinical population 
Introduction 
Suicidality, suicidal ideation and suicidal behaviour, is a significant health concern for 
adolescents with Autism Spectrum Disorders (ASD).  Depression and Irritability have been 
identified as risk factors for suicidality in autistic adolescents.  Autistic youth may have 
higher vulnerability to these factors than typically-developing adolescents.  No study has 
compared the relationship between suicidality and different depressive profiles, nor used a 
UK clinical sample.   
Aims 
The aim of the study was to identify risk factors for suicidality in a clinical sample of 
adolescents with ASD, specifically exploring the roles of depression and irritability as 
potential risk factors.  Furthermore, this study compared the relationship between suicidality 
and individual depressive and irritability profiles.  Based on current knowledge, the following 
hypotheses were made: 
Hypothesis 1.  Depression will be identified as a significant risk factor for suicidality 
in adolescents with ASD. 
Hypothesis 2.  Irritability will be identified as a significant risk factor for suicidality 
in adolescents with ASD. 
Hypothesis 3.  Part of the relationship, if not all, between irritability and suicidality 
will be explained by depression. 
Hypothesis 4.  Depression with co-occurring irritability will be a stronger predictor 
for suicidality in adolescents with ASD than both depression without co-occurring irritability 
and irritability without co-occurring depression. 
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Method 
This clinical cohort study used archival data extracted from UK National Institute for 
Health Research Biomedical Research Centre for Mental Health records database.  The 
sample consisted of 1314 adolescents (13+ years) who received an ICD-10 ASD diagnosis 
between 2008 and 2013.  The study investigated the following variables: 
• Outcome Variable: Suicidality (suicidal ideation and/or suicidal behaviour) 
• Main Exposure Variables: 
o Depression,  
o Irritability 
o Specific profile presentations: 
▪ Depression with co-occurring irritability (DWI) 
▪ Depression without co-occurring irritability (DNI) 
▪ Irritability without co-occurring depression (IND) 
Results 
Cross-sectional analysis found depression to be associated with higher likelihood of 
suicidality.  Irritability was found to be associated with higher likelihood of suicidality, even 
after controlling for depression.  DWI was a more significant predictor of suicidality than 
IND, but no different from DNI.  Psychosis, being female, antidepressant use, and caregiver 
mental health difficulties were also positively associated with suicidality, but significantly 
less likely in individuals diagnosed with an intellectual disability.   
Conclusions 
Results indicate multiple characteristics of adolescents with ASD at high-risk of 
suicidality.  Early identification of high-risk individuals could help deliver timely 
intervention, potentially reducing both incidence and progression of suicidality.   
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Appendix F: Author guidelines of journal chosen for submission of empirical paper 
Research in Autism Spectrum Disorders – Guide for Authors 
Editorial Process  
All submissions will first be checked against the Aims and Scope and Guide for Authors by 
the Editor-in-Chief. Papers found to conform, in principle, to the journal's remit and 
standards will be assigned to a handling Editor (an Associate Editor or the Editor-in-Chief) 
for further evaluation. If a paper meets the journal's criteria a minimum of two independent 
reviewers will be invited to comment on the paper's methodological rigour and significance. 
Based on these comments and additional opinions if necessary, the handling Editors will 
make a decision. All accepted papers will therefore have received comments from a 
minimum of two independent reviewers and be reviewed by one or more editors. Please note 
that RASD currently operates single-blinded peer review. 
Human and Animal Rights  
If the work involves the use of animal or human subjects, the author should ensure that the 
work described has been carried out in accordance with The Code of Ethics of the World 
Medical Association (Declaration of Helsinki) for experiments involving 
humans http://www.wma.net/en/30publications/10policies/b3/index.html; EU Directive 
2010/63/EU for animal 
experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm; 
Uniform Requirements for manuscripts submitted to Biomedical 
journalshttp://www.icmje.org. Authors should include a statement in the manuscript that 
informed consent was obtained for experimentation with human subjects. The privacy rights 
of human subjects must always be observed. All animal studies need to ensure they comply 
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with the ARRIVE guidelines. More information can be found 
at http://www.nc3rs.org.uk/page.asp?id=1357 
Elsevier supports responsible sharing  
Find out how you can share your research published in Elsevier journals. 
 
The gold open access publication fee for this journal is USD 2200, excluding taxes. Learn 
more about Elsevier's pricing policy: https://www.elsevier.com/openaccesspricing. 
Green open access  
Authors can share their research in a variety of different ways and Elsevier has a number of 
green open access options available. We recommend authors see our green open access 
page for further information. Authors can also self-archive their manuscripts immediately and 
enable public access from their institution's repository after an embargo period. This is the 
version that has been accepted for publication and which typically includes author-
incorporated changes suggested during submission, peer review and in editor-author 
communications. Embargo period: For subscription articles, an appropriate amount of time is 
needed for journals to deliver value to subscribing customers before an article becomes freely 
available to the public. This is the embargo period and it begins from the date the article is 
formally published online in its final and fully citable form. Find out more. 
Elsevier Researcher Academy  
Researcher Academy is a free e-learning platform designed to support early and mid-career 
researchers throughout their research journey. The "Learn" environment at Researcher 
Academy offers several interactive modules, webinars, downloadable guides and resources to 
guide you through the process of writing for research and going through peer review. Feel 
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free to use these free resources to improve your submission and navigate the publication 
process with ease. 
MANUSCRIPT PREPARATION & SUBMISSION 
Use of word processing software  
Files must be saved in the native format of the word processor and the text should be in 10-
point Arial font, single-column format, double spaced, with standard 1 inch page margins 
(2.54 cm). Please keep the layout of the text as simple as possible, as most formatting codes 
will be replaced on processing the article. In particular, do not use the options to justify text 
or hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. Note that 
source files of figures and text graphics will be required whether or not you embed them in 
the text. See also the section on Electronic artwork below for details on preparing figures and 
graphics. 
Language (usage and editing services)  
Please write your text in good English (American or British usage is accepted, but not a 
mixture of these). Authors who feel they require support in editing to eliminate possible 
grammatical or spelling errors and to conform to correct scientific English may wish to use 
the English Language Editing service available from Elsevier's WebShop 
(http://webshop.elsevier.com/languageediting/). 
In relation to terminology, we prefer authors to refrain from using the terms 'low-functioning' 
or 'high-functioning' to describe individuals with ASD who either have additional intellectual 
or language impairments or not (see Kenny et al., 2015; 
http://aut.sagepub.com/content/early/2015/06/10/1362361315588200.abstract). Instead 
authors should consider whether it may be appropriate to provide details about their 
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participants in terms of the severity specifiers of the DSM-5 (American Psychiatric 
Association, 2013). 
Types of Articles  
Research in Autism Spectrum Disorders publishes the following types of manuscripts: 
Brief reports: Papers of no more than 2,500 words that report an original piece of research 
of limited scope and/or that serves as proof-of principle for larger-scale studies. 
Regular Articles: Papers of up to 6,000 words that report a substantive piece of research that 
makes a significant contribution and has clear implications for practice. Manuscripts 
reporting the results of randomized trials or interventions must demonstrate adherence to the 
CONSORT guidelines (http://www.consort-statement.org/) and include the relevant flow 
diagram and completed checklist. 
Reviews: Papers of up to 10,000 words that provide a comprehensive overview of a 
significant area of research. Quantitative (e.g., meta-analyses) and qualitative reviews are 
welcome as long as they go beyond a mere description of the available literature and 
synthesise new knowledge with clear implications for future directions and practice. For 
systematic reviews and meta-analyses, authors must demonstrate adherence to the PRISMA 
guidelines (www.prisma-statement.org) and include the relevant flow diagram and checklist. 
Commentaries: We welcome brief commentaries of no more than 1,000 words that offer 
new insights on papers published in RASD or elsewhere. Commentaries on government 
policy and/or items in the media are also welcome. 
NOTE: Word limits do not include the title page, abstract, figure legends, tables and 
reference list. 
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Submission  
Our online submission system guides authors stepwise through the submission process. The 
system converts article files to a single PDF file used in the peer–review process. Editable 
files (e.g., Word, LaTeX) are required to typeset your article for final publication. All 
correspondence, including notification of the Editor's decision and requests for revision, is 
sent by e–mail. 
 
Elsevier accepts electronic supplementary material such as supporting applications, high 
resolution images, background datasets, sound clips and more. These will be published online 
alongside the electronic version of your article in Elsevier Web products, including 
ScienceDirect: http://www.sciencedirect.com. For further information, please visit our 
artwork instruction pages at http://www.elsevier.com/artworkinstructions 
 
The journal also encourages authors to submit an AudioSlides presentation with their 
published article. AudioSlides are brief, webinar-style presentations that are shown next to 
the online article on ScienceDirect, giving authors the opportunity to showcase their work 
more readily. More information and examples are available at 
http://www.elsevier.com/audioslides. Authors of articles in this journal will automatically 
receive an invitation e–mail to create an AudioSlides presentation after acceptance of their 
paper. 
 
To increase the transparency of editorial information within the framework of single/ double 
blind peer review, RASD displays the number of unique reviewer reports received in the first 
round of review with each published article. This policy will be in place for original research 
articles submitted from 1 January 2016 that are accepted for publication. 
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Manuscript Format  
All manuscripts must include a Title, Abstract and Highlights on separate pages, followed by 
the main manuscript text. The main manuscript text of brief reports, regular articles and 
quantitative reviews should include subsections carrying the headings Introduction, Methods, 
Results, Discussion & Implications. Reviews may deviate from this structure but must 
include a methods section that provides details on how the relevant literature was searched. 
The structure of commentaries is at the discretion of authors. 
Essential Title Page Information  
Title: Titles must be concise and informative and should have no more than 20 words. Titles 
are often used in information–retrieval systems. Avoid abbreviations and formulae where 
possible. 
Author names and affiliations: Please clearly indicate the given name(s) and family 
name(s) of each author and check that all names are accurately spelled. Present the author's 
affiliation addresses (where the actual work was done) below the names. Indicate all 
affiliations with a lowercase superscript letter immediately after the author's name and in 
front of the appropriate address. Provide the full postal address of each affiliation, including 
the country name and, if available, the e–mail address of each author. 
Corresponding author: Clearly indicate who will handle correspondence at all stages of 
refereeing and publication, also post-publication. Ensure that the e–mail address is given 
and that contact details are kept up to date by the corresponding author. 
Present/permanent address: If an author has moved since the work described in the article 
was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be 
indicated as a footnote to that author's name. The address at which the author actually did the 
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work must be retained as the main affiliation address. Superscript Arabic numerals are used 
for such footnotes. 
Abstract & Keywords  
The abstract page must include a structured abstract of no more than 250 words that includes 
the following subsections:  
Background: A brief summary of the research question and rationale for the study. 
Method: A concise description of the methods employed to test the stated hypotheses, 
including details of the participants where relevant. 
Results: A brief description of the main findings. 
Conclusions: This section must include a clear statement about the implications of the 
findings for practice. 
 
Immediately after the abstract, a maximum of 6 keywords should be provided, avoiding 
general and plural terms and multiple concepts (for example, avoid 'and', 'of'). Be sparing 
with abbreviations: only abbreviations firmly established in the field may be eligible (e.g., 
ADOS, ASD, etc). These keywords will be used for indexing purposes. 
Graphical Abstract  
Graphical abstracts are optional but encouraged to draw more attention to the online article. 
The graphical abstract should summarize the contents of the article in a concise, pictorial 
form designed to capture the attention of a wide readership. Graphical abstracts should be 
submitted as a separate file in the online submission system. Please provide an image with a 
minimum of 531 X 1328 pixels (h X w) or proportionally more. The image should be 
readable at a size of 5 X13 cm using a regular screen resolution of 96 dpi. Preferred file types 
include TIFF, EPS, PDF or MS Office files. 
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See http://www.elsevier.com/graphicalabstracts for examples. Authors can make use of 
Elsevier's Illustration and Enhancement service to ensure the best presentation of their 
images. 
http://webshop.elsevier.com/illustrationservices/ 
Introduction  
The introduction should develop a clear rationale for the presented work on the basis of a 
concise overview of the relevant literature. Detailed literature reviews should be avoided. 
Methods  
This section will typically include sub–headings for a description of the Participants, 
Materials & Design, Procedures and Analysis. However, alternative sub–headings may be 
used to suit particular research approaches (e.g., case–studies, meta–analyses, imaging 
studies etc.) 
 
The participants section should provide demographic information (age, sex, ethnicity, socio–
economic status, etc.), and include details on where and how participants were recruited and 
how relevant clinical diagnoses were verified. Additional clinical information (e.g., 
intellectual functioning, co–morbidities, use of medication etc.) is desired and may be 
necessary for some research designs. Sample sizes should be justified by suitable power 
calculations although it is appreciated that it is not always feasible to obtain desired numbers 
of participants. 
 
The materials, design and procedures must be described in sufficient detail for the work to be 
replicable. Authors must also include a statement confirming that the work was carried out in 
accordance with the ethical standards of the responsible committee on human 
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experimentation (institutional and national) and with the Declaration of Helsinki as revised in 
2000. In this context confirmation should also be given that participant or guardian informed 
consent was obtained where appropriate. 
 
The analysis section should provide details of the statistical methods used including 
information on the significance thresholds and the methods used to correct for multiple 
comparisons where necessary. Information on inter–rater reliability and any data filtering / 
transformation that was applied should also be included here. 
Results  
The results should be set out transparently and in full and should conform to the formatting 
style of the American Psychological Association (http://www.apastyle.org/). Effect sizes 
must be reported for all significant and non–significant effects, and sufficient descriptive 
statistics must be provided for the effect size calculations to be replicated. 
Tables  
Please submit tables as editable text and not as images. Tables can be placed either next to the 
relevant text in the article, or on separate page(s) at the end. The formatting of tables should 
conform to APA guidelines (http://www.apastyle.org/). 
Figures & Artwork  
General points 
• Make sure you use uniform lettering and sizing of your original artwork.  
• Embed the used fonts if the application provides that option. 
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, 
Symbol, or use similar fonts. 
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• Number the illustrations according to their sequence in the text.  
• Use a logical naming convention for your artwork files.  
• Provide captions to illustrations separately.  
• Size the illustrations close to the desired dimensions of the published version.  
• Submit each illustration as a separate file. 
 
For Vector drawings, the recommended file format is EPS or PDF (embed all used fonts).  
For all other artwork, please use TIFF or JPEG file formats with the following resolutions:  
• Colour or grayscale photographs (halftones): 300 dpi  
• Pure black & white line drawings: 1000 dpi  
• Combination halftone and black & white: 500dpi 
Please do not:  
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG)  
• Supply files that are too low in resolution;  
• Submit graphics that are disproportionately large for the content. 
 
If, together with your accepted article, you submit usable colour figures, Elsevier will ensure, 
at no additional charge, that these figures will appear in colour online (e.g., ScienceDirect and 
other sites) regardless of whether or not these illustrations are reproduced in colour in the 
printed version. For colour reproduction in print, you will receive information regarding 
the costs from Elsevier after receipt of your accepted article. Please indicate your 
preference for colour: in print or online only. For further information please 
see http://www.elsevier.com/artworkinstructions. 
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Video Data  
Elsevier accepts video material and animation sequences to support and enhance presentation 
of your scientific research. Authors who have video or animation files that they wish to 
submit with their article are strongly encouraged to include links to these within the body of 
the article. This can be done in the same way as a figure or table by referring to the video or 
animation content and noting in the body text where it should be placed. All submitted files 
should be properly labelled so that they directly relate to the video file's content. In order to 
ensure that your video or animation material is directly usable, please provide the files in one 
of our recommended file formats with a preferred maximum size of 150 MB. Video and 
animation files will be published online in the electronic version of your article in Elsevier 
Web products, including ScienceDirect: http://www.sciencedirect.com. 
 
Please supply 'stills' with your files; you can choose any frame from the video or animation or 
make a separate image. These will be used instead of standard icons and will personalize the 
link to your video data. For more detailed instructions, please visit our video instruction 
pages at http://www.elsevier.com/artworkinstructions. Note: since video and animation 
cannot be embedded in the print version of the journal, please provide text for both the 
electronic and the print version for the portions of the article that refer to this content. 
3D neuroimaging  
You can enrich your online articles by providing 3D neuroimaging data in NIfTI format. This 
will be visualized for readers using the interactive viewer embedded within your article, and 
will enable them to: browse through available neuroimaging datasets; zoom, rotate and pan 
the 3D brain reconstruction; cut through the volume; change opacity and colour mapping; 
switch between 3D and 2D projected views; and download the data. The viewer supports 
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both single (.nii) and dual (.hdr and .img) NIfTI file formats. Recommended size of a single 
uncompressed dataset is maximum 150 MB. Multiple datasets can be submitted. Each dataset 
will have to be zipped and uploaded to the online submission system via the '3D 
neuroimaging data' submission category. Please provide a short informative description for 
each dataset by filling in the 'Description' field when uploading a dataset. Note: all datasets 
will be available for downloading from the online article on ScienceDirect. If you have 
concerns about your data being downloadable, please provide a video instead. For more 
information see: http://www.elsevier.com/3DNeuroimaging. 
Discussion and Implications  
The discussion section should draw together the findings and must end with a clear indication 
of the implications of the findings for practice under a separate subheading (Implications). 
Acknowledgements  
Collate acknowledgements in a separate section at the end of the main manuscript text and 
before the references. List here any sources of funding (including grant numbers where 
relevant) and briefly describe the role of the sponsor(s), if any, in study design; the collection, 
analysis or interpretation of data; the writing of the report; and the decision to submit the 
article for publication. If the funding source(s) had no such involvement then this should be 
stated. 
Conflict of interest  
At the end of the main manuscript text and before the references, authors must disclose any 
actual or potential conflict of interest including any financial, personal or other relationships 
with other people or organizations within three years of beginning the submitted work that 
could inappropriately influence, or be perceived to influence, their work. If no such conflict 
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of interest exists, this must be clearly stated. For further information and examples of conflict 
of interest statements please visit the 
following: http://www.elsevier.com/conflictsofinteresthttp://service.elsevier.com/app/answers
/detail/a_id/286/supporthub/publishing A decision may be made by the Journal not to publish 
on the basis of the declared conflict. 
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In–text citations should conform to the formatting style of the American Psychological 
Association (http://www.apastyle.org/). Please ensure that every reference cited in the text is 
also present in the reference list (and vice versa). Any references cited in the abstract must be 
given in full 
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packages. This covers packages using the Citation Style Language, such as Mendeley 
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(http://www.endnote.com/support/enstyles.asp) and Reference Manager 
(http://refman.com/support/rmstyles.asp). For example, if you manage your research with 
Mendeley Desktop, you can easily install the reference style for RASD through this 
link: http://open.mendeley.com/use-citation-style/research-in-autism-spectrum-disorders 
 
 139 
 
 
[dataset] Oguro, M., Imahiro, S., Saito, S., Nakashizuka, T. (2015). Mortality data for 
Japanese oak wilt disease and surrounding forest compositions. Mendeley Data, v1. 
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der Geer, J., Hanraads, J. A. J., & Lupton, R. A. (2010). The art of writing a scientific article. 
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Mettam, G. R., & Adams, L. B. (2009). How to prepare an electronic version of your article. 
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York: E–Publishing Inc. 
Cover Letter  
All submissions must be accompanied by a cover letter to confirm that the work described 
has not been published previously (except in the form of an abstract or as part of a published 
lecture or academic thesis or as an electronic preprint, 
see http://www.elsevier.com/sharingpolicy), that it is not under consideration for publication 
elsewhere, that its publication is approved by all authors and tacitly or explicitly by the 
responsible authorities where the work was carried out, and that, if accepted, it will not be 
published elsewhere in the same form, in English or in any other language, including 
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electronically, without the written consent of the copyright–holder. To verify originality, your 
article may be checked by the originality detection service 
CrossCheck http://www.elsevier.com/editors/plagdetect 
 
If a submission is to be considered for a special issue, authors are asked to indicate this also 
in their cover letter. 
Submission checklist  
The following list will be useful during the final checking of an article prior to sending it to 
the journal for consideration. Please refer to relevant sections above for guidance if you are 
not yet in a position to confirm all of the following points. 
Ensure that the following items are present: 
• The title page is complete, one author has been designated as the corresponding author and 
contact details are provided (e-mail; full postal address) 
• All necessary files have been uploaded and include all necessary sections 
• All figures have been uploaded and figure captions are provided separately  
• All tables are clear and include relevant captions and footnotes 
• The manuscript has been 'spell&checked' and 'grammar–checked' References are in the 
correct format.  
• All references mentioned in the Reference list are cited in the text, and vice versa 
• Permission has been obtained for use of copyrighted material from other sources (including 
the Internet)  
• All sources of funding have been acknowledged and the authors have either declared 
conflicts of interest or confirmed that none exist  
• The manuscript gives due consideration to the practical implications of the work, which are 
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clearly stated in the abstract and thoroughly considered in a final section of the discussion 
 
For any further information please visit our customer support site 
at http://support.elsevier.com. 
Data references  
This journal encourages you to cite underlying or relevant datasets in your manuscript by 
citing them in your text and including a data reference in your Reference List. Data 
references should include the following elements: author name(s), dataset title, data 
repository, version (where available), year, and global persistent identifier. Add [dataset] 
immediately before the reference so we can properly identify it as a data reference. The 
[dataset] identifier will not appear in your published article. 
AudioSlides  
The journal encourages authors to create an AudioSlides presentation with their published 
article. AudioSlides are brief, webinar-style presentations that are shown next to the online 
article on ScienceDirect. This gives authors the opportunity to summarize their research in 
their own words and to help readers understand what the paper is about. More information 
and examples are available. Authors of this journal will automatically receive an invitation e-
mail to create an AudioSlides presentation after acceptance of their paper. 
Data visualization  
Include interactive data visualizations in your publication and let your readers interact and 
engage more closely with your research. Follow the instructions hereto find out about 
available data visualization options and how to include them with your article. 
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Research data  
This journal encourages and enables you to share data that supports your research publication 
where appropriate, and enables you to interlink the data with your published articles. 
Research data refers to the results of observations or experimentation that validate research 
findings. To facilitate reproducibility and data reuse, this journal also encourages you to share 
your software, code, models, algorithms, protocols, methods and other useful materials 
related to the project. 
Below are a number of ways in which you can associate data with your article or make a 
statement about the availability of your data when submitting your manuscript. If you are 
sharing data in one of these ways, you are encouraged to cite the data in your manuscript and 
reference list. Please refer to the "References" section for more information about data 
citation. For more information on depositing, sharing and using research data and other 
relevant research materials, visit the research data page. 
Data linking  
If you have made your research data available in a data repository, you can link your article 
directly to the dataset. Elsevier collaborates with a number of repositories to link articles on 
ScienceDirect with relevant repositories, giving readers access to underlying data that gives 
them a better understanding of the research described. 
There are different ways to link your datasets to your article. When available, you can 
directly link your dataset to your article by providing the relevant information in the 
submission system. For more information, visit the database linking page. 
For supported data repositories a repository banner will automatically appear next to your 
published article on ScienceDirect. 
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In addition, you can link to relevant data or entities through identifiers within the text of your 
manuscript, using the following format: Database: xxxx (e.g., TAIR: AT1G01020; CCDC: 
734053; PDB: 1XFN). 
Mendeley Data  
This journal supports Mendeley Data, enabling you to deposit any research data (including 
raw and processed data, video, code, software, algorithms, protocols, and methods) 
associated with your manuscript in a free-to-use, open access repository. Before submitting 
your article, you can deposit the relevant datasets to Mendeley Data. Please include the DOI 
of the deposited dataset(s) in your main manuscript file. The datasets will be listed and 
directly accessible to readers next to your published article online. 
For more information, visit the Mendeley Data for journals page. 
Data statement  
To foster transparency, we encourage you to state the availability of your data in your 
submission. This may be a requirement of your funding body or institution. If your data is 
unavailable to access or unsuitable to post, you will have the opportunity to indicate why 
during the submission process, for example by stating that the research data is confidential. 
The statement will appear with your published article on ScienceDirect. For more 
information, visit the Data Statement page. 
 
Online proof correction  
Following acceptance, corresponding authors will receive an e–mail with a link to our online 
proofing system, allowing annotation and correction of proofs online. The environment is 
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similar to MS Word: in addition to editing text, you can also comment on figures/tables and 
answer questions from the Copy Editor. Web–based proofing provides a faster and less error–
prone process by allowing you to directly type your corrections, eliminating the potential 
introduction of errors. If preferred, you can still choose to annotate and upload your edits on 
the PDF version. All instructions for proofing will be given in the e–mail we send to authors, 
including alternative methods to the online version and PDF. 
 
We will do everything possible to get your article published quickly and accurately. Please 
use this proof only for checking the typesetting, editing, completeness and correctness of the 
text, tables and figures. Significant changes to the article as accepted for publication will only 
be considered at this stage with permission from the Editor. It is important to ensure that all 
corrections are sent back to us in one communication. Please check carefully before replying, 
as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your 
responsibility. 
Changes to authorship  
This policy concerns the addition, deletion, or rearrangement of author names in the 
authorship of accepted manuscript Before the accepted manuscript is published in an online 
issue: Requests to add or remove an author, or to rearrange the author names, must be sent to 
the Journal Manager from the corresponding author of the accepted manuscript and must 
include: (a) the reason the name should be added or removed, or the author names rearranged, 
and (b) written confirmation (e–mail, fax, letter) from all authors that they agree with the 
addition, removal or rearrangement. In the case of addition or removal of authors, this 
includes confirmation from the author being added or removed. Requests that are not sent by 
the corresponding author will be forwarded by the Journal Manager to the corresponding 
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author, who must follow the procedure as described above. Note that: (1) Journal Managers 
will inform the Journal Editors of any such requests, and (2) publication of the accepted 
manuscript in an online issue is suspended until authorship has been agreed. 
 
After the accepted manuscript is published in an online issue: Any requests to add, delete, or 
rearrange author names in an article published in an online issue will follow the same policies 
as noted above and result in a corrigendum. 
Copyright  
Upon acceptance, an e–mail will be sent to the corresponding author confirming receipt of 
the manuscript together with a 'Journal Publishing Agreement' form or a link to the online 
version of this agreement (for more information on this and copyright, 
see http://www.elsevier.com/copyright). As an author you (or your employer or institution) 
have certain rights to reuse your work (see http://www.elsevier.com/copyright). 
 
Subscribers of the journal may reproduce tables of contents or prepare lists of articles 
including abstracts for internal circulation within their institutions. Permission of the 
Publisher is required for resale or distribution outside the institution and for all other 
derivative works, including compilations and translations (please 
consult http://www.elsevier.com/permissions). If excerpts from other copyrighted works are 
included, the author(s) must obtain written permission from the copyright owners and credit 
the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: 
please consult http://www.elsevier.com/permissions 
Open access  
For open access articles authors will be asked to complete an 'Exclusive License Agreement' 
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(for more information see http://www.elsevier.com/OAauthoragreement). An open access 
publication fee of USD 1800 (excluding taxes) is payable by authors or on their behalf 
(see http://www.elsevier.com/openaccesspricing). 
 
Permitted third party reuse of open access articles is determined by the author's choice of user 
license (see http://www.elsevier.com/openaccesslicenses). 
 
Creative Commons Attribution (CC BY) Lets others distribute and copy the article, create 
extracts, abstracts, and other revised versions, adaptations or derivative works of or from an 
article (such as a translation), include in a collective work (such as an anthology), text or data 
mine the article, even for commercial purposes, as long as they credit the author(s), do not 
represent the author as endorsing their adaptation of the article, and do not modify the article 
in such a way as to damage the author's honour or reputation. 
 
Creative Commons Attribution–NonCommercial–NoDerivs (CC BY–NC–ND) For non–
commercial purposes, lets others distribute and copy the article, and to include in a collective 
work (such as an anthology), as long as they credit the author(s) and provided they do not 
alter or modify the article. 
Green open access  
Authors can share their research in a variety of different ways and Elsevier has a number of 
green open–access options available. We recommend authors see our green open–access page 
for further information (http://elsevier.com/greenopenaccess). Authors can also self–archive 
their manuscripts immediately and enable public access from their institution's repository 
after an embargo period. This is the version that has been accepted for publication and which 
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typically includes author–incorporated changes suggested during submission, peer review and 
in editor–author communications. Embargo period: For subscription articles, an appropriate 
amount of time is needed for journals to deliver value to subscribing customers before an 
article becomes freely available to the public. This is the embargo period and begins from the 
publication date of the issue your article appears in. This journal has an embargo period of 24 
months 
Funding body agreements and policies  
Elsevier has established a number of agreements with funding bodies which allow authors to 
comply with their funder's open access policies. Some authors may also be reimbursed for 
associated publication fees. To learn more about existing agreements please 
visit http://www.elsevier.com/fundingbodies. 
Use of the Digital Object Identifier  
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The 
DOI consists of a unique alpha–numeric character string which is assigned to a document by 
the publisher upon the initial electronic publication. The assigned DOI never changes. 
Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because 
they have not yet received their full bibliographic information. Example of a correctly given 
DOI (in URL format; here an article in the journal Physics Letters 
B) http://dx.doi.org/10.1016/j.physletb.2010.09.059 
When you use a DOI to create links to documents on the web, the DOIs are guaranteed never 
to change. 
Offprints  
The corresponding author, at no cost, will be provided with a personalized link providing 50 
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days of free access to the final published version of the article on ScienceDirect. This link can 
also be used for sharing via email and social networks. For an extra charge, paper offprints 
can be ordered via the offprint order form which is sent once the article is accepted for 
publication. Both corresponding and co–authors may order offprints at any time via Elsevier's 
WebShop (http://webshop.elsevier.com/myarticleservices/offprints). 
Authors requiring printed copies of multiple articles may use Elsevier WebShop's 'Create 
Your Own Book' service to collate multiple articles within a single cover 
(http://webshop.elsevier.com/myarticleservices/booklets). 
 
